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ABSTRACT
Accurate quantitative information of tumor/lesion volume plays a critical role
in diagnosis and treatment assessment. The current clinical practice emphasizes on
efficiency, but sacrifices accuracy (bias and precision). In the other hand, many com-
putational algorithms focus on improving the accuracy, but are often time consuming
and cumbersome to use. Not to mention that most of them lack validation studies on
real clinical data. All of these hinder the translation of these advanced methods from
benchside to bedside.
In this dissertation, I present a user interactive image application to rapidly extract
accurate quantitative information of abnormalities (tumor/lesion) from multi-spectral
medical images, such as measuring brain tumor volume from MRI. This is enabled by
a GPU level set method, an intelligent algorithm to learn image features from user
inputs, and a simple and intuitive graphical user interface with 2D/3D visualization.
In addition, a comprehensive workflow is presented to validate image quantitative
methods for clinical studies.
This application has been evaluated and validated in multiple cases, including
quantifying healthy brain white matter volume from MRI and brain lesion volume from
CT or MRI. The evaluation studies show that this application has been able to achieve
comparable results to the state-of-the-art computer algorithms. More importantly,
the retrospective validation study on measuring intracerebral hemorrhage volume
from CT scans demonstrates that not only the measurement attributes are superior
to the current practice method in terms of bias and precision but also it is achieved
without a significant delay in acquisition time. In other words, it could be useful to the
clinical trials and clinical practice, especially when intervention and prognostication
rely upon accurate baseline lesion volume or upon detecting change in serial lesion
i
volumetric measurements. Obviously, this application is useful to biomedical research
areas which desire an accurate quantitative information of anatomies from medical
images. In addition, the morphological information is retained also. This is useful
to researches which require an accurate delineation of anatomic structures, such as
surgery simulation and planning.
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Chapter 1
INTRODUCTION
Healthcare generates tremendous amounts of data everyday. These data range
from genetics to tissues and organs, from one person to a large population. How
to effectively use this data to extract information and obtain knowledge for better
analysis and decision making becomes the main question of biomedical informatics.
Among all of the data, a large portion is generated from modern medical imaging
modalities. Medical images enable physicians to peer through the patient’s body
non-invasively. Various medical imaging techniques cover every part of the human
body to provide both structural and functional information. Biomedical imaging
informatics is an active research field which deals with medical imaging data. The
field of biomedical imaging informatics encompasses multiple areas in the medical
imaging workflow including digital image acquisition, image content representation,
image management/storage, image processing, and image interpretation and computer
reasoning.
My research belongs to the image processing step, which extracts information
from medical images to assist decision making and image analysis in the next step.
Currently, qualitative information is mostly used in the clinical practice. What really
wanted is quantitative information, which are numerical values that can be compared
and computed. One simple and common quantitative information from medical images
is size. Here are several examples of how size could be used in either clinical practice
and biomedical research: sizes of the brain over time show brain atrophy, which
is associated with either normal aging or neurological disease, such as Alzheimer’s
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disease; sizes of lesions such as multiple sclerosis lesion is used to tell the stage of
disease; change of hemorrhage sizes within hours indicates the speed of hematoma
growth, which is a strong predictor of patient care outcome.
However, most of the information is qualitative in clinical practice. A survey on
the radiology charts from a hospital showed that less than half of the charts contain
any quantitative metrics while only less than 3% use advanced quantitative metrics.
The measurement of size is even less. In other words, this is rarely used in practice.
In clinical trials, diameter based methods are normally used which estimates the
volume of an object using one or two axes in millimeters. It is simple and rapid to use,
but suffers high bias and variability. In order to achieve acceptable results, manual
outlining by experts such as radiologists or trained technicians is often used. But
manual outlining is very time consuming and not clinically feasible. It is conducted
mostly in biomedical research which requires to track object size over time. On the
other hand, there are image segmentation algorithms which perform similar tasks. My
research uses the level set method, which requires the user to place seed points to grow
and evolves iteratively to extract the targeted object. It has been proven to obtain
acceptable results from medical images but is neither simple nor rapid. Previous effort
had accelerated level set method with graphical processing units (GPU), which solved
part of the problem why level set method is slow. However several parameters which
need to be specified by the user hinder the simplicity and rapidness of level set method.
The long term goal is to develop a quantitative image method to measure size from
medical images that satisfy three criteria: 1) simple, 2) rapid, and 3) accurate (low
bias and variability).
In this dissertation, I present this amazing tool we developed to extract quantitative
information from medical images and its evaluation and validation on brain white
2
matter, multiple sclerosis lesion, and intracerebral hemorrhage stroke. These studies
show that this toolkit has minimal user interaction and intuitive graphical user
interface (simple), is on par with the less accurate measurement methods used in
clinical practice or trials (rapid), and has small bias and low variability (accurate).
This application provides a simple, rapid, and reliable way to extract quantitative
information from medical images. This information is very useful to assist further anal-
ysis and better decision making. It could be used to extract quantitative information
from CT or MRI data which provides a high resolution of structural informations. For
instance, it could be used to track the size change of solid tumors, which is related to
cancer research and treatment response. In addition, it could be used to measure organ
volume, like liver or kidney, to aid transplant surgeries. But there are some limitations.
This application is not reliable when using low resolution functional images, such
as functional MRI data. Another limitation is brought by the low contrast between
targeted object and surrounding regions.
Figure 1. A demonstration of using diameter based method to measure liver tumors
(the dark region) inside the liver (light gray area). The left figure shows the tumor
size (4.5 cm) from the baseline CT scan before treatment . The right figure shows the
tumor size (3.2 cm) from the follow up CT scan after treatment.
3
Chapter 2 covers the background of this research, from biomedical imaging in-
formatics to image segmentation algorithms using commodity graphics card. Then,
Chapter 3 and 4 present the developments of our method, applying to extract brain
white matter region and multiple sclerosis lesions (brain lesions) from MR images.
Chapter 5 presents a comprehensive clinical validation study to evaluate the bias,
precision, and measurement time for our method to quantify intracerebral hemorrhage
volume from CT images. Chapter 6 discusses the impact of our method to both
clinical practice and researches. In the end, Chapter 7 concludes this dissertation.
4
Chapter 2
BACKGROUND
2.1 Biomedical Imaging Informatics
Biomedical imaging informatics is a subdiscipline of biomedical informatics. As
a fast evolving research field at the crossing of medicine, informatics, and computer
science and engineering, it plays a critical role in clinical practices, education, and
research. The field of biomedical imaging informatics encompasses multiple areas
in the medical image workflow including digital image acquisition, image content
representation, image management/storage, image processing, image interpretation
and computer reasoning (Shortliffe and Cimino, 2006). For instance, a patient with
severe pain in the arm is prescribed an X-ray of his/her arm (digital image acquisition).
The X-ray image is stored as a digital format into the radiology image database and
management system (image content representation and image management/storage).
This image could be enhanced by adjusting brightness and contrast (image processing)
for better and easier examination. After the image is ready to review, the radiologist
opens the image from his workstation, identifies a bone fracture, potentially aided by
computer software (image interpretation/computer reasoning).
There are two strategies in imaging the body. The first is structure imaging,
delineating anatomic structure. Structure imaging captures a high spatial resolution
image to accurately represent the structure of the body, including healthy organs and
abnormalities. Both CT and MRI are popular structure imaging modalities with high
spatial resolution. Computed Tomography (CT) is cross sectional and volumetric
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images, reconstructed from the radiation attenuation of a series of X-ray projected
from various angels throughout the human body (Buzug, 2008). The intensity at
each voxel (volume element), representing the density of the tissue in that position, is
estimated using computer reconstruction algorithms. Magnetic Resonance Imaging
(MRI) uses the body’s natural magnetic properties to produce detailed images from
any part of the body (Berger, 2002).
The second strategy is functional imaging, determines tissue composition or
function, which has been an active research area recent years, especially functional
brain imaging modalities. Positron Emission Tomography (PET) shows high functional
information but low spatial resolution (Mettler Jr and Guiberteau, 2011). It uses
positron emitters for producing the image. In addition, new technologies have been in
development to combine structure and functional imaging. For instance, PET/CT
combines the characteristics of PET and CT images to visualize low resolution
functional PET scan on top of high spatial resolution CT scan. Presently, most
clinical studies use a combination of modalities to generate both structural and
functional information.
Medical image processing The increasingly prominent role of medical imaging
in medical diagnosis and treatment leads to the challenging problem of extracting
clinically useful information about anatomic structures from modern medical images
using computers. Although modern imaging devices provide high-resolution views of
internal anatomy, the use of computers to quantitatively analyze anatomic structures
with reliability and efficiency is limited. Accurate and quantitative information must be
efficiently extracted in order to support clinical practice and research. Like all digital
data, medical images can be manipulated and processed with computational algorithms.
There are a broad variety of image processing methods including: transformations
6
Figure 2. Images of the brain from three modalities (Left: T1 without contrast,
middle: T1 with contrast, and right: T2). A brain tumor is located in the left side of
the image.
to enhance visualization, computations to extract features, and systems to automate
detection or diagnose abnormalities in the images. When applying these image
processing methods to medical images, it faces unique and different challenges even
though it uses similar methods of general image processing. One of the differences
is that these data are 3D volumetric data. Since most of the images are from multi-
modalities (CT, MRI, PET), they are treated as a multi-spectral images with more
channels than regular images with only three channels (Red, Green, Blue). In addition,
each modality has its own unique physical characteristics, thus causing unique noise,
contrast and other issues. The fusion/co-registration of information across several
modalities is a challenge that needs to be addressed as well.
2.2 Medical Image Segmentation
Image segmentation is one of the most challenging and researched tasks in image
processing. It is employed as one of the most fundamental processes in extracting
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quantitative and geometry information of a region of interest (ROI) from medical
image data, and it determines the quality of the healthcare outcome (Fitzpatrick and
Sonka, 2000; Demirkaya et al., 2009). The goal of medical image segmentation is to
automatically or semi-automatically delineate anatomic structures and other ROI
from medical images. Then quantitative information and characteristics of the ROIs
can be extracted.
One common scenario to obtain accurate tumor volume is manually delineating the
tumor boundary in 2D axial slices by trained experts, which are later reconstructed
to 3D surface by software, such as OsiriX (Rosset et al., 2004). The manual method
is often used to create ground truth, precise and accurate but time consuming, for
validation of computer algorithms. Researchers have proposed many automatic and
semi-automatic methods for the segmentation of anatomical structures from medical
images using computers.
• Gray-level thresholding is the early and simple segmentation method. In this
approach, we assign a label to objects by comparing their gray-level value to one
or more intensity thresholds (Fitzpatrick and Sonka, 2000). It is often effective
for images in which different structures have high contrast intensities but difficult
to handle image noise.
• Parametric Deformable models (McInerney and Terzopoulos, 1996), such as
Snake (Kass et al., 1988; Xu and Prince, 1998) are model-based techniques
for delineating region boundaries using closed parametric curves or surfaces
under the influence of internal and external forces. The level set method is a
non-parametric deformable model (Osher and Sethian, 1988a; Malladi et al.,
1995; Caselles et al., 1993). Deformable models provide the user with efficient
interactivity. But, in order to detect the boundary, a curve or surface must be
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placed near the desired boundary before the iterative process. In addition, it
requires longer computational time to achieve acceptable results.
• Active shape models statistically learn the variance of the object’s shape, and
constrain its topology and general shape to obtain the segmentation (Cootes et al.,
1995). In addition, active appearance models (Cootes et al., 1998) incorporate
appearance priors (intensity value) and shape. These methods are useful to
extract anatomic structures with similar shapes, such as the liver and lung. But
they may not be effective to segment objects with large shapes variation.
• Live wire (Falcao et al., 1998; Mortensen and Barrett, 1998) and fuzzy connect-
edness methods (Udupa and Samarasekera, 1996; Saha and Udupa, 2000) are
semi-automated segmentation methods that are based on finding optimal paths
with dynamic programming techniques. These methods treat the images as
graphs. These methods are easy and intuitive for the use and have the added
advantage of providing the results in real time. But they are also sensitive to
noise; the user cannot adjust the smoothness of the boundary.
• Image segmentation with graph cut (Boykov and Jolly, 2001; Boykov and
Kolmogorov, 2004) partitions an image into foreground and background by
computing a globally optimal cut. It requires users to select seed points for both
foreground and background. Grabcut (Rother et al., 2004) extends graph cut to
an iterative process. Random walk (Grady, 2006) is another graph-based image
segmentation algorithm. These methods are computationally expensive for high
dimensional images.
A comparison of computer assisted image segmentation algorithms is shown in Ta-
ble 2.2.
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Table 1. Comparison of Advanced Image Segmentation Methods
Approach Pros Cons
Deformable model 1) Easily manipulated using
external image forces. 2) Can
be used to track dynamic ob-
jects in temporal and spatial
dimensions. 3) Users are able
to guide the snake with mouse
actions.
1) Have to place contour near
the desired boundary. 2) Sen-
sitive to noises and local min-
imum. 3) Cannot merge or
split contour. 4) Longer com-
putational time in order to
achieve more accurate results.
Livewire 1) Easy and intuitive for the
use 2) Show the result in real-
time. 3) Easy to implement.
1) Sensitive to noise. 2) Can-
not adjust smoothness. 3) Re-
quire more user interaction for
more difficult tasks.
Graph Cut 1) Fast inference. 2) Incorpo-
rate recognition or high-level
priors. 3) Easily extend to 3D
image segmentation.
1) Only apply to binary seg-
mentation. 2) No uncertainty
measure associated with the
solution. 3) Leakage on weak
edges.
Random Walk 1) Segment multiple objects.
2) Robust on weak edges. 3)
Return probabilistic value to
the final segmentation 4) Only
one parameter
Computationally expensive for
high dimensional images.
Level Set 1) Implicit surface representa-
tion. 2) Manipulate less pa-
rameters of the surface or con-
tour. 3) Easily follow the topo-
logical shape changes, such as
split, merge, ect.
1) Time consuming since solv-
ing a partial differential equa-
tion every iteration. 2)
Difficult to prevent leakage
through weak boundaries.
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2.2.1 Level Set Method
The level set method is popular for 3D medical image segmentation due to its
robustness on 1) handling noisy images and 2) handling topological changes such as
merging and splitting. In this section, I discuss this method in detail because it serves
as a foundation for my research.
The level set method embeds an implicit surface within an image, and iteratively
deforms the surface to envelop the containing ROI. To better explain the concept,
here is an instance of a 2D case (Figure 3). In an 2D image, the level set method
represents the 2D contour with the zero level set of a 3D surface. The propagation
of the contour becomes the 3D surface evolution. Each point on this 3D surface
moves along the direction which is perpendicular to the local surface. And how fast it
moves is determined by a speed function based on the image features and local surface
curvature. The algorithms begin with a user-placed seed region of interest (ROI).
Then the ROI is deformed iteratively to encompass the entire ROI, in our scenario, the
tumor or lesion. In addition to the seed region, several adjustment parameters (related
to image intensities and surface smoothness) control the growth and smoothness of
the ROI surface and can be specified by the user.
The implicitly represented level set surface is defined as {x|φ(x, t) = 0}, where x
is a coordinate in the image volume, t is the current iteration time in the level set
evolution, and φ(x, t) : <4 7→ < refines the level set according to:
φ(x, t) = φ(x, t−∆t) +∇t · F (x, t)|∇φ(x, t−∆t)|. (2.1)
A speed function F (x) defines the rate of motion of each local point on the implicit
surface. The deforming direction of each point is along the norm of the local surface.
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Figure 3. An illustration of the level set method in a 2D image. The top row shows
the 2D shape change and split. The bottom row shows the corresponding change of
the implicit 3D level set surface (red surface). The blue plane is the zero level set.
We adopted the speed function proposed by Lefohn et al.:
F (x, t) = αC(x, t) + (1− α)D(x), (2.2)
where C(x, t) is the curvature term, D(x) is the data term, and α ∈ [0, 1], the weight
of curvature term, is a blending term that controls the relative contribution of the
curvature and data terms.
The data term used in Lefohn et al. is a function of intensities in a single image
volume:
D(x) = − (|I(x)| − T ), (2.3)
where I(x) is the image intensity at location x, T is a user-specified target intensity
that encourages maximum level set growth, and  is a user-specified parameter that
indicates the range of intensities around T that will promote level set growth. If
T −  < I(x) < T + , then D(x) will promote surface growth. Otherwise it will
promote surface contraction.
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The curvature term C(x, t) depends upon the mean curvature of the local surface
from the previous iteration:
C(x, t) = ∇ · ∇φ(x, t−∆t)|∇φ(x, t−∆t)| . (2.4)
A degree of curvature prevents critical leakage through weak boundaries and fills holes
caused by noise inside the segmented region. Excessive smoothing by overly penalizing
curvature can significantly distort segmented objects. Eventually, when the weight of
the curvature term α is too large (close to 1), the level set surface will shrink to a
point.
This approach presents unique advantage over the parametric deformable model.
The surface represented by the level set function handles the topological changes
naturally by seamlessly developing sharp corners, breaking or merging during the
evolution. It has been proven that level set method is very useful with three or higher
dimensional segmentation problems as the surfaces become inherently complex for
parametric representation (Sethian, 1999). However, level set segmentation has been
too computationally expensive and time consuming for widespread clinical practice.
Graphics processing units (GPU) was originally designed to process and render
computer graphics. GPU’s architecture is composed of thousands of small processors
in order to process computational tasks for pixels, while central processing unit (CPU)
only uses several powerful processing cores. Thanks to the boom of video game industry,
GPUs have been getting better and better with more computational powers, larger
memory bandwidth, and increasing programmability. In the past ten years, GPUs
become extremely popular for scientific computing which are often computational
expensive. They significantly accelerate applications in the fields ranging from artificial
intelligence to robotics, from computer vision to big data analysis.
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2.3 General Purpose Computation Using Graphics Processing Units (GPGPU)
In the last decade, researchers have started to deploy GPU as a massively parallel
platform to accelerate general computations. General purpose computation on graphic
processing units (GPGPU) employs commodity graphical hardware, which typically
render computer graphics, to perform computations traditionally handled by the
central processing unit (CPU) (Eklund et al., 2013). With increasing programmability
and higher precision arithmetic processing (Figure 4), GPUs demonstrate potential
as cost-effective and high performance computing platforms for various applications.
Medical image processing also benefit from the parallelism of GPUs. Medical imaging
applications (NVIDIA, 2012), such as image registration, high-dimensional image
denoising, and image segmentation (Figure 5). It could enable practical use of
computationally demanding algorithms, such as level set method.
2.4 GPU Level Set Segmentation
Lefohn et al. started a GPU-based interactive level set segmentation in 2003 and
showed the potential of GPU acceleration on narrowband level set method, which
solves the problem by limiting the computation in a thin band around the propagating
surface (Lefohn et al., 2003a,b, 2004). Cates et al. integrated Lefohn’s algorithm and
implemented a tool called GIST for 3D medical image segmentation (Cates et al.,
2004). More recently, Roberts et al. developed a new GPU level set algorithm, which
is 16x faster than the previously fastest GPU level set (Roberts et al., 2010). First,
this method limits the active computational domain to the minimal set of changing
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Figure 4. Floating-Point Operations per Second for the CPU and GPU. (CUDA
programming guide, 2013)
Figure 5. The figure shows the cumulative number of publications for GPU-based
medical imaging algorithms (Eklund et al., 2013).
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elements by examining both the temporal and spatial derivative of the level set field.
Second, it is a work- and step-efficient ∗implementation of this algorithm for GPU
architectures. These features minimize the size of the active computational domain
to remain small as the algorithm progresses. Meanwhile, it requires less memory than
previous GPU algorithms. These innovations allow the algorithm to work quickly on
very large image volumes. In addition, GPU level set methods allow user interactive
(real-time) segmentation because the level set computation and graphic rendering are
simultaneously handled in the GPU memory.
∗A parallel algorithm is work-efficient, or simply “efficient”, if it performs the same amount of
work, to within a constant factor, as the fastest known sequential algorithm. And a parallel algorithm
is step-efficient if the amount of steps is comparable to known sequential algorithms. For example,
we want to add a constant value to each element of an N elements array. There will be N addition
operations (work) to achieve the task for both sequential and parallel algorithms. However if we
have N processors from our GPU, the parallel algorithm could map each addition operation on one
processor and finish the whole operations within one step (N operations / N processor). So the work
complexity of the parallel algorithm is N, while its step complexity is 1.
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Chapter 3
INTELLIGENT INITIALIZATION AND INTERACTIVITY: OPTIMIZING LEVEL
SETS FOR T1-WEIGHTED WHITE MATTER SEGMENTATION
The level set surface evolution is controlled by the speed function (Eq. 2.2), which
requires users to specify serveral parameters, which are related to local intensities
and growth penalties based on surface smoothness. Each parameter demands user
experience with the tool, intuition relating parameter adjustments to changes in the
result, and knowledge of the intensities and surface smoothness of the target brain
structures. First, we present a method to optimally specify the three parameters to
segment region of interest (ROI) from medical images directly without user input. We
develop a novel non-parametric data term and optimally specify α based on imaging
noise levels. In addition, we demonstrate the user interactive segmentation tool. It has
a graphical user interface and could visualize the medical images and segmentation
in 2D and 3D view. This method was evaluate to segment brain white matter from
T1-weighted MRI phantom data, of which ground truth is provided.
My contributions in this manuscript are 1) algorithm development and implemen-
tation, 2) method evaluation, and 3) drafting and revising the manuscript.
This manuscript is presented in the Interactive Medical Image Computing (IMIC)
Workshop at MICCAI 2014 conference.
Authors: Wenzhe Xue1, Christine M. Zwart2, and J. Ross Mitchell3
Affiliation:
1. Department of Biomedical Informatics, Arizona State University, Scottsdale, AZ
2. Department of Radiology, Mayo Clinic, Scottsdale, AZ
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Abstract White matter (WM) segmentation from T1-weighted MRI is compli-
cated by intensity non-uniformities, noise, and WM’s high surface area to volume
ratio. Accurate algorithms are often computationally intensive and time consuming,
precluding interactivity and routine clinical use. To address this we developed a
work- and step-efficient parallel narrow-band level set algorithm and mapped this
onto commodity GPU hardware. Our algorithm can segment brain WM in 3 seconds.
However, it requires expert tuning of 3 parameters. Here we describe recent efforts to
improve the precision, accuracy and simplicity of WM segmentation by: a) intelligently
initializing algorithm parameters; and, b) allowing interactive parameter tuning during
algorithm execution, along with real-time 2D and 3D visualization of parameter effects
on segmentation results.
3.1 Introduction
MRI provides high spatial resolution and soft tissue contrast. Consequently,
it is widely used for research and clinical neurological studies. Changes in brain
morphometry have been linked to childhood development, healthy aging, neurological
disorders, and psychiatric disorders. In particular, white matter (WM) develops
dramatically through infancy (Giedd et al., 1999) and undergoes significant atrophy
as part of healthy aging (Ge et al., 2002). WM volume changes can be a very sensitive
(if not specific) indicator of Alzheimer’s disease and other disorders (Hirono et al.,
2000; Sanfilipo et al., 2006).
In the past two decades, a wealth of MR image segmentation algorithms have
been developed for automatic or semi-automatic segmentation of WM and other brain
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structures. Segmentation techniques range from intensity thresholding, to region-based
or edge-based methods, to active contour models and level set methods. Despite
advances in theoretical approaches, clinics and clinical research laboratories still rely
heavily on trained technicians manually delineating regions of interest on each 2D
cross-section and then extrapolating to 3D surfaces (Brinkley and Rosse, 2002). The
computation time required for many sophisticated algorithms precludes routine clinical
use.
Minimally interactive, user-initiated approaches with manual refinement are often
proposed as an ideal solution (Brinkley and Rosse, 2002). Among these algorithms,
the level set approach is popular because of its flexibility and robustness (Sethian,
1999; Osher and Fedkiw, 2001). The level set (and most region growing) approaches
begin with a user-placed seed region of interest (ROI), for example in the WM on the
image. The algorithm then iteratively deforms the seed ROI to encompass the entire
‘related’ area, in our scenario, the entire WM. In addition to the seed region, several
algorithm parameters explicitly and intrinsically control the growth and smoothness
of the ROI surface. These may include the relative weights of external forces acting
on the contour, intensity threshold(s), and a surface smoothness parameter.
Even when the user specification of parameters is well-managed and streamlined
(such as in ITK-SNAP (Yushkevich et al., 2006), a popular semi-automatic seg-
mentation tool), long computation times preclude a truly ‘interactive’ approach to
segmentation. This is particularly true for level sets - the delay between parameter
adjustments and outcomes prohibits fine tuning. Approaches to streamline parameter
adjustment into a sequential process provides a false sense of fine tuning as the coarse
parameters become unavailable baring a fresh start.
A recent work- and step-efficient GPU implementation of the level set method
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(Roberts et al., 2010) has provided a 14x acceleration over the best previously published
GPU approach (Lefohn et al., 2003a). A validation study of brain tumor segmentation
with the new algorithm showed tumor segmentation times averaging just 1:20 (mm:ss).
This was slightly faster than diameter-based approaches frequently used in clinical
trials, yet provided volume quantification results statistically equivalent to a consensus
of manual, slice-by-slice, contour delineations by experts (gold standard) (Dang
et al., 2013). Furthermore, the speed function used in those studies (Roberts et al.,
2010; Dang et al., 2013) to control the level set surface evolution required specifying
only three parameters (intensity window and level and a growth penalty based on
surface smoothness). Nevertheless, tuning each parameter to obtain acceptable results
required user experience and intuition. Interactive parameter adjustment during
algorithm execution, coupled with real time visual feedback of parameter effects on
segmentation results, can significantly narrow the intuition gap between novice and
experienced users. This is particularly true for high contrast spherical structures
(e.g., meningiomas). MRI intensity inhomogeneity, noise, and the complicated surface
structure of WM hinders effective parameter selection and, in turn, rapid and accurate
brain WM segmentation.
In this paper, we describe a novel approach to initializing the three parameters
for GPU level set segmentation of WM in T1 weighted MRI brain images, directly,
without user input of specific thresholds or values. Initially, users mark foreground
and background seed pixels using a paint-brush style interface. A fuzzy classification
model of the seed ROI intensities then controls the local growth and contraction of
the level set. Next, we use an empirically determined relationship between curvature,
segmentation accuracy, and image noise to predict the optimal curvature influence.
Finally, the graphical user interface permits visualizing the growth of the level set
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curve as it is computed and permits adjustment of the curvature parameter in real
time while observing the surface progression in two or three dimensions. Each of these
aspects is reviewed in the Methods (Section 2) prior to coverage of our white matter
segmentation results (Section 3) and a brief discussion (Section 4). Videos of our tool
and other additional materials have been provided online as well (see Section 5).
3.2 Methods
3.2.1 Level Sets
Level set methods embed an implicit surface within an image, and iteratively
deform the surface to envelop the ROI. Several comprehensive reviews of level set
methods and their application to image segmentation are well-documented in the
medical image analysis literature (Sethian, 1999). Here we review the formulation
relevant to our algorithm.
The implicitly represented level set surface is defined as {x|φ(x, t) = 0}, where x
is a coordinate in the image volume, t is the current iteration time in the level set
evolution, and φ(x, t) : <4 7→ < refines the level set according to:
φ(x, t) = φ(x, t−∆t) +∇t · F (x, t)|∇φ(x, t−∆t)|. (3.1)
A speed function F (x) defines the rate of motion of each local point on the implicit
surface. The deforming direction of each point is along the norm of the local surface.
Our previous GPU level set algorithm (Roberts et al., 2010) adopted the speed function
proposed in (Lefohn et al., 2003a):
F (x, t) = αC(x, t) + (1− α)D(x), (3.2)
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where C(x, t) is the curvature term, D(x) is the data term, and α ∈ [0, 1], the weight
of curvature term, is a blending term that controls the relative contribution of the
curvature and data terms.
The data term used in (Lefohn et al., 2003a) is a function of intensities in a single
image volume:
D(x) = − |I(x)− T |, (3.3)
where I(x) is the image intensity at location x, T is a user-specified target intensity
that encourages maximum level set growth, and  is a user-specified parameter that
indicates the range of intensities around T that will promote level set growth. If
T −  < I(x) < T + , then D(x) will promote surface growth. Otherwise it will
promote surface contraction.
The curvature term C(x, t) depends upon the mean curvature of the local surface
from the previous iteration:
C(x, t) = ∇ · ∇φ(x, t−∆t)|∇φ(x, t−∆t)| . (3.4)
Penalizing curvature prevents critical leakage through weak boundaries and fills holes
caused by noise inside the segmented region. Excessive smoothing by overly penalizing
curvature (assigning larger value to α) can significantly distort the shape of target
objects. Eventually, when α is too large (close to 1), the level set surface will shrink
to a point.
The speed function defined by Eq. 3.2 relies on three user-specified parameters:
α, , and T . T and  define the local intensity force; α defines the contribution of the
curvature term. In this paper, we describe a non-parametric approach for specifying
the data term, replacing T and  with user seeding of foreground and background
pixels. We further suggest an approach to initializing α based on the application (WM
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segmentation in T1 weighted MR) and image noise, thereby minimizing non-intuitive
user input.
3.2.2 Non-parametric Data Term
We propose a novel non-parametric data term (in place of Eq. 3.3) based on the
k nearest neighbor (k-NN) algorithm (Duda et al., 2000). k-NN algorithms classify
objects by assigning the label of majority among the k nearest training samples in
feature space. The training data contain samples belonging to either foreground or
background. This introduces the added requirement for users to seed both foreground
and background voxels. The data term is then defined as a function of relative distance
(intensity difference) to the background and foreground classes.
For voxel x with intensity I(x), the distance to background dB(x) and distance
to foreground dF (x) samples are assigned as the mean of distances to the kB and kF
nearest background and foreground samples:
dB(x) =
1
kB
kB∑
k=1
|I(x)− VB(k)|; (3.5)
dF (x) =
1
kF
kF∑
k=1
|I(x)− VF (k)|. (3.6)
kB =
√
NB and kF =
√
NF , where NB and NF are the numbers of background and
foreground samples respectively. VB and VF are sorted feature (intensity) vectors of
background and foreground samples.
The new data term is formed based on both distances:
D(x) =
dB(x)− dF (x)
dB(x) + dF (x)
, (3.7)
and is in the range [−1, 1]. Positive values indicate the voxel is closer to the foreground
class, and negative values indicate the voxel is closer to the background class. The
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function is zero-valued when the distances to both classes are equal. Substituting Eq.
3.7 for Eq. 3.3 eliminates user-defined parameters T and .
3.2.3 Curvature Weighting Term
In Eq. 3.2, the user-controlled weighting parameter α determines the relative
cost of increased curvature. Changes in α over the full theoretical range of values
(α ∈ (0, 1)) can significantly impact the segmentation results. For a given application
the reasonable range of values for α can be greatly reduced and the initial value
for α can be automatically assigned more intelligently than, for example, setting
an arbitrary starting point (e.g., α = 0.5). This places the user into a fine-tuning
and final adjustment role that requires less time, training, and improves the overall
algorithm precision. In Section 3.3.2, we briefly review experiments used to define the
optimal starting value for α for based on an empirical relationship between curvature,
image noise, and WM segmentation accuracy (Figure 9).
3.2.4 Software and User Interface
Our tool provides an interactive rendering window with 2D axial or 3D views.
Users can quickly switch between 2D and 3D view modes with a shortcut key. In
the 3D view, our tool renders the image volume as well as the segmentation results,
allowing qualitative validation.
In the first step of the segmentation, users initialize the level set by sketching seed
points on axial slices with a paint-brush tool. Users are required to label background
samples (out of the targeted ROI) and foreground samples (in the targeted ROI). After
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pressing the “play” button, the level set iteratively grows to envelop the structures of
interest. Due to our unique GPU implementation, both the level set and visualization
algorithms share data buffers. This allows interactive tuning of algorithm parameters
along with real-time 2D or 3D visualization of the parameter effects on segmentation
results. Users can go back to the previous segmentation step using the undo button.
In addition, users can manually edit the segmentation results (adding or erasing) using
a paint-brush tool with an adjustable width parameter in the 2D axial slices.
3.3 Results
3.3.1 White Matter Segmentation
We performed WM segmentation on synthetic MRI brain phantoms generated
from the BrainWeb Simulated Brain Database (Collins et al., 1998). The BrainWeb
phantoms are available with a variety of realistic noise characteristics and the ground
truth classification of each voxel is known. We tested on six noise levels (SNR = ∞,
100, 33, 20, 14, 11) with 0% RF inhomogeneity, used eight sets of seed points, and
sixteen α values ranging from 0 to 0.30 (step-size of 0.02). RF inhomogeneity was
not varied due to the availability of effective approaches to bias correction (Tsang
et al., 2008). The eight sets of seed points were placed by 3 independent users and
saved for repeated measurements. In total 768 WM segmentations were performed (6
SNR levels x 8 sets of seed regions x 16 α values). For each segmentation, accuracy
was evaluated relative to the BrainWeb classification (truth) by computing Dice’s
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Figure 6. The 3D view of level set propogation in BrainWeb data (SNR = 33 and RF
= 0%). The overall accuracy (Dice coefficient) of level set segmentation of white
matter across the entire brain was 97%. The GPU level set (including kNN
computation) required 3s to execute. Total segmentation time, inlcuding data loading
and user interaction, was 20s.
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Figure 7. The difference between our level set segmentation and Brainweb ground
truth, in the axial slice with the greatest number of errors.
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Figure 8. Level set results on patient images. The figures in the left column show the
axial slices (selected to be at a location similar to Fig. 7. The right column shows the
segmentation results obtained using our method.
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coefficient (Dice), a measure of spatial overlap ranging from 0 to 1, with 1 indicating
perfect overlap.
3.3.2 Optimized Curvature Term
Figure 9. The relationship between accuracy, SNR, and α for 768 WM segmentations
of BrainWeb T1-weighted MR phantoms. A surface plot (left), shows the mean Dice’s
coefficient (accuracy) (z-axis) for different SNR values (x-axis) and curvature
parameters (y-axis). We then fit a function along the path of peak accuracy in this
surface. The resulting 3rd order polynomial (right) allows us to estimate the α value
that maximizes accuracy for a particular image noise level σ2n.
Plotting the Dice’s coefficient for each of the segmentation experiments described
above allowed us to establish an empirical relationship between the image noise, α, and
accuracy (Figure 9). Using this relationship, the initial curvature weight, αinit, can be
selected (based on estimates of image noise) according to a third degree polynomial
(determined by a curve fitting algorithm):
αinit = f(σ
2
n) = −0.001(σ2n)3 + 0.0133(σ2n)2 − 0.0154σ2n + 0.08 (3.8)
For clinical data with unknown noise, the estimated noise variance, σ2n = 1/SNR,
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can be computed using the fast noise estimation method proposed by Immerker
(Immerkæ r, 1996). The curvature parameter can then be initialized using Eq. 3.8
without any user experience or intuition (users are still able to tune α afterward).
Over the range of image noise levels evaluated, the value for α (taken from the
discrete subset tested) corresponding to the average (over the eight seed point sets) of
the peak Dice coefficients varied considerably (Table 2). In contrast, the optimal α
for each seed point set in a fixed noise level varied much less and the fine-tuning of α
from the noise-based initial value to the experimentally-defined optimal α had limited
impact on the accuracy (Table 3).
Table 2. The maximum Dice and corresponding α for each SNR value tested. The
optimal α values range from 0.08 to 0.3.
SNR 100 33 20 14 11
Max. Dice 0.9712 0.9674 0.9550 0.9419 0.9310
α 0.08 0.12 0.22 0.28 0.3
Table 3. The maximum Dice and corresponding α for each set of input seed points
when SNR=33. For comparison, the accuracy for fixed α = 0.12 is also provided.
User 1 2 3 4 5 6 7 8
Max. Dice 0.9669 0.9683 0.9682 0.9679 0.9683 0.9671 0.9664 0.9657
α 0.06 0.10 0.12 0.12 0.12 0.14 0.12 0.14
Dice (α = 0.12) 0.9668 0.9683 0.9682 0.9679 0.9683 0.9671 0.9664 0.9656
3.4 Discussion
Requiring users to adjust parameters increases segmentation variability, and in-
convenience. Iterative refinement of parameters may also increase segmentation time.
In general, the tuning process requires expertise and hinders use in clinical settings.
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Our new approach provides precise, accurate, rapid and simple WM segmentation
in T1-weighted brain MR scans. It does not require prior knowledge of appropriate
parameter values, nor extensive parameter tuning to obtain acceptable results. We
accomplished this through three novel contributions: 1) a GPU level set speed function
driven by a non-parametric k-NN data model built from the seed ROI intensities; 2) a
new empirical relationship between WM segmentation accuracy, image noise, and the
level set curvature parameter, α; and, 3) a GPU implementation where both the level
set and visualization algorithms share data buffers. This allows interactive tuning of
algorithm parameters along with real-time 2D or 3D visualization of the parameter
effects on segmentation results.
Future efforts will focus on validating our method for WM segmentation in other
imaging modalities, such as T2-weighted MRI. We will also extend the method for
segmentation of brain gray matter and ventricles.
3.5 Supplementary Material
We have used our tool to segment a variety of objects from MR and CT datasets. A
video of our tool segmenting brain WM (from T1-weighted MRI) and brain vasculature
(from contrast enhanced CT) is available here: http://goo.gl/2K98Gs.
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Chapter 4
A NEW ITERATIVE GPU ALGORITHM TO SEGMENT MS LESIONS IN
MULTI-SPECTRAL MRI DATASETS
As mentioned in Chapter 2, multiple medical imaging modalities add much more
information to monitor the disease progress during treatment. In this chapter, we
present an novel method to extract brain lesions from multiple segmentations of brain
white matter from multi-spectral MRI. MS lesion is very difficult to identify and
extract from a single contrast MRI. It’s necessary to use multi-spectral images. We
explore a unique approach of using our previous algorithm to solve such a sophisticated
task. In particular, this new approach is feasible only by leveraging the speed of our
GPU level set algorithm. We evaluate our method on both MRI phantom and real
patient MRI data. We demonstrate that our method is able to achieve the accuracy
comparable to the state-of-the-art algorithms in seconds.
My contributions in this manuscript are 1) algorithm development and implemen-
tation, 2) method evaluation, and 3) drafting the manuscript.
Currently, we plan to submit this manuscript to the journal of NeuroImage.
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Wingerchuk3, and J. Ross Mitchell4
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Abstract This paper presents a new method to segment MS lesions in multi-
spectral MRI exams. Our approach leverages the speed of a GPU level set algorithm
to perform multiple segmentations of brain white matter in each exam. Differences
between these segmentations allow us to estimate the distribution of MS lesions. A
new data term in the level set speed function eliminates the need to store MR exams
on the GPU memory. This allows multi-spectral MRI exams that are too large to fit on
the GPU to be processed efficiently. We evaluated our method on BrainWeb and MS
lesion segmentation challenge 2008 data. It achieved results comparable to, or better
than, two top performing algorithms. The average time required by our algorithm to
segment lesions in the MS Lesion segmentation Challenge 2008 data was 20.8 seconds.
Current limitations include the need for a user to seed three regions in each exam.
Future work will focus on automating the seed placement step using statistical and/or
atlas-based co-registration approaches. Finally, better post-processing methods may
reduce false positive lesions.
4.1 Introduction
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the
central nervous system (CNS). Typical manifestations of MS include motor weakness,
gait disorder, and impairment of sensory, visual, and cognitive function. These are
caused, in part, by focal inflammatory lesions that disrupt CNS white matter pathways.
Magnetic resonance imaging (MRI) is widely used to diagnose MS and evaluate disease
activity over time.
Focal MS white matter lesions typically appear hyperintense on T2 weighted
(T2w) and fluid-attenuated inversion recovery (FLAIR) T2 MRIs, and isointense or
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hypointense on non-contrast enhanced T1 weighted (T1w) MRIs. Such lesions can be
visually distinguished from surrounding “normal-appearing white matter” (NAWM).
Accurate and reproducible quantitative measurement of MS lesion volumes aids dis-
ease tracking, therapeutic assessment, and cognitive research. However, segmentation
of MS lesions is generally quite difficult due to their highly variable size, distribution,
and intensity patterns. Consequently, manual identification and segmentation of MS
lesions is often performed by experts such as physicians or trained technicians. But
this process is time consuming and plagued by low intra- and inter-operator reliability.
Completely automated approaches are also used. These often employ two important
components to extract MS lesions: preprocessing and segmentation. Preprocessing of
head MRI typically includes spatial co-registration, intensity inhomogeneity correction,
and brain extraction. Intensity normalization is used when the segmentation compo-
nent involves a training process and thus requires the intensity of the analyzed image
to be similar to the intensity of training images. Image features used for automatic
identification of MS lesions include normalized intensity, texture measures, location
and shape (García-Lorenzo et al., 2013). Completely automated approaches may
require long execution times. Furthermore, in clinical research settings, their output
must be reviewed by a human expert for both false-positive and false-negative results.
The review and correction process can be time consuming.
Minimally interactive, user-initiated approaches with manual refinement are often
proposed as an ideal compromise for general medical image segmentation (Brinkley
and Rosse, 2002; Menze et al., 2014). These methods combine the human expert’s
ability to identify normal and pathological regions, with the computer’s computational
power. Computer assisted MS lesion detection and segmentation methods have been
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an active area of research for several decades (Brosch et al., 2015; Freire and Ferrari,
2016; García-Lorenzo et al., 2013, 2009; Mitchell et al., 1994; Styner et al., 2008).
This paper describes two primary contributions. The first of these is a novel
method to segment MS lesions from multi-spectral MRI. Our approach builds upon
an existing general purpose GPU level set algorithm (Roberts et al., 2015, 2010).
This GPU algorithm is optimal in the sense that it is both work and step efficient.
It is also 14x faster than the fastest prior parallel level set algorithm (Lefohn et al.,
2004). It allows rapid, low bias and low variability segmentation of neurological tissues,
including brain tumors (Dang et al., 2013) and total white matter (WM) volume (Xue
et al., 2014). The latter required less than 3 seconds to complete.
The second primary contribution is a new data term in the level set speed function.
This term eliminates the need to store MRI exams on the GPU memory, as in prior
approaches. Instead, a fixed size data and seed dependent lookup table is employed.
This allows multi-spectral MRI exams that are too large to fit on the GPU memory
to be processed efficiently using our algorithm.
4.2 Methods
4.2.1 Development and Validation Environment
All development and validation were performed on a workstation running Windows
7 (Microsoft, Redmond WA.). This workstation had an Intel (Santa Clara, CA.) Xeon
8-core 3.6GHz CPU, 64GB RAM, and an Nvidia (Santa Clara, CA.) GTX Titan GPU
(6GB VRAM and 2688 CUDA cores). Our application was implemented in C++ and
CUDA (V6.0) using Visual Studio 2008 (Microsoft).
35
Figure 10. MS lesion segmentation on a representative axial T2-weighted image from
the BrainWeb data with moderate lesion load. Segmentation proceeds in four steps:
(a) the user places seeds: NAWM seeds are green; CSF and gray matter (GM) seeds
are red; and, lesion seeds are yellow. (b) the GPU level set labels all white matter
(AWM, including NAWM and MS lesions) in 3D; (c) the GPU level set labels NAWM
in 3D; (d) the post-processed difference between (b) and (c) is used to estimate the
distribution of MS lesions. A close up comparison between our estimate and truth is
shown in Fig. 11. When our method was tested on the MS Lesion Segmentation
Challenge 2008 dataset, the average execution time per exam was 20.8 seconds.
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4.2.2 Background
4.2.2.1 Level Set Methods
Level set methods embed an implicit surface within an image, and iteratively
deform the surface for segmentation (Sethian, 1999). The implicitly represented level
set surface is defined as {x|φ(x, t) = 0}, where x is a coordinate in the image volume,
t is the current iteration time in the level set evolution, and φ(x, t) : <4 7→ < refines
the level set according to:
φ(x, t) = φ(x, t−∆t) +∇t · F (x, t)|∇φ(x, t−∆t)|. (4.1)
A speed function F (x) defines the rate of motion of each local point on the implicit
surface. The deforming direction of each point is along the norm of the local surface.
Our previous GPU level set algorithm adopted the speed function proposed in (Lefohn
et al., 2004):
F (x, t) = αC(x, t) + (1− α)D(x), (4.2)
The curvature term C(x, t) depends upon the mean curvature of the local level set
surface from the previous iteration:
C(x, t) = ∇ · ∇φ(x, t−∆t)|∇φ(x, t−∆t)| . (4.3)
And the data term is defined as a function of intensities in a single image volume:
D(x) = − |I(x)− T |, (4.4)
where I(x) is the image intensity at location x, T is a user-specified target intensity
that encourages maximum level set growth, and  is a user-specified parameter that
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indicates the range of intensities around T that will promote level set growth. If
T −  < I(x) < T + , then D(x) will promote surface growth. Otherwise it will
promote surface contraction.
The parameter α, in the range [0, 1], controls the relative contributions of the
curvature and data terms. Our level set executes quickly enough that surface growth
can be visualized interactively in two or three dimensions. Consequently, the user
can adjust α and see the effect in real time. Higher α values encourage smoother,
smaller volumes, while lower values encourage larger, more irregular volumes. Several
adjustments to α are sometimes required to obtain a satisfactory segmentation,
especially for complex shapes such as brain white matter. To address this, we
previously developed an empirical approach to optimally initialize α based on image
noise (Xue et al., 2014). In this paper, similar experiments were performed to find
optimal α values for MS lesion segmentation in patient exams (described below).
4.2.2.2 Non-parametric Data Term
In (Xue et al., 2014) we proposed a non-parametric data term D(x) based on the
k nearest neighbor (kNN) classification (Duda et al., 2000). This eliminated the need
for the user to specify T and . Instead, the user performed a more intuitive operation:
they drew one or more short strokes (placed seeds) in desired tissues (foreground,
colored green in our implementation), and undesired tissues (background, colored red)
(Fig. 10a).
D(x) is then a function of the relative difference, or distance, between I(x) and the
background and foreground intensities determined from the seed samples. For a voxel
x, the distance to background, dB(x), and distance to foreground, dF (x), samples are
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assigned the mean of distances to the kB and kF nearest background and foreground
samples:
dB(x) =
1
kB
kB∑
k=1
|I(x)− VB(k)|; (4.5)
dF (x) =
1
kF
kF∑
k=1
|I(x)− VF (k)|. (4.6)
kB =
√
NB and kF =
√
NF , where NB and NF are the numbers of background
and foreground samples respectively. VB and VF are feature (intensity) vectors of
background and foreground samples, sorted by distance to I(x).
The new data term is then defined as:
D(x) =
dB(x)− dF (x)
dB(x) + dF (x)
, (4.7)
and is in the range [−1, 1]. Positive values promote surface growth, while negative
values promote contraction. The function is zero-valued when the distances to both
classes are equal.
4.2.2.3 Extension to Multi-spectral Image Volumes
We extended I(x) to be a vector, supporting multiple contrast values at each
spatial location. Equations (4.5) and (4.6) are modified to indicate vector valued
image volumes:
dB(x) =
1
kB
kB∑
k=1
|~I(x)− VB(k)|; (4.8)
dF (x) =
1
kF
kF∑
k=1
|~I(x)− VF (k)|. (4.9)
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The kNN distance computation to background and foreground samples then occurs
in a higher-dimensional feature space. Also, since D(x) depends only upon dB(x)
and dF (x) it can be pre-computed on the CPU and transferred to the GPU. This
eliminates the requirement to store ~I(x) on the GPU, as in (Roberts et al., 2010, 2015).
This is significant since ~I(x) may be too large to fit into GPU memory, especially for
high spatial resolution image volumes with multiple intensity values at each spatial
location. The drawback is that D(x) must be recomputed on the CPU and transferred
to the GPU whenever the user specifies new background or foreground seeds, since
that could alter dB(x) or dF (x), respectively. However, this process requires only a
few seconds, and is typically much quicker than the time the user required to specify
new seeds. In our experience this relatively short delay is well tolerated by users.
4.2.3 MS Lesion Segmentation
Since the time penalty for segmentation with our GPU level set is small, multiple
segmentations of large regions in a single neurological MRI dataset are possible in a
clinically practical time frame. We leverage this to repeatedly segment the total WM
volume, while varying the level set initialization parameters between iterations.
We begin by segmenting all white matter (AWM, including NAWM and MS
lesions). Then, through successive iterations, we adjust the initialization parameters
to constrain the segmentation towards NAWM alone. Differences between these
repeated segmentations allow us to estimate the spatial distribution of MS lesions.
In theory, the more segmentations we perform, the better our estimate will become.
Here, as a proof of concept, we perform only two segmentations of WM - the minimum
possible with our scheme.
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To accomplish this, we introduce a new workflow that requires the user to label
seed points for three tissues (Fig. 10a): 1) NAWM (green), 2) other brain regions
(gray matter and CSF, red), and 3) one or more MS lesions (yellow). Using these
three clusters of seed voxels, our method performs two separate segmentations. The
first is to extract AWM, and the second is to extract NAWM.
Segmentation of AWM To segment AWM, our method uses seed voxels of
NAWM and MS lesion as foreground samples, and seed voxels from other brain regions
as background samples. Equations (4.8), (4.9) and (4.7) are calculated and used to
guide the propagation of the level set surface. The result is an estimate of the AWM
region, XAWM .
Segmentation of NAWM To segment NAWM, our method uses seed voxels of
NAWM as foreground samples and seed voxels of MS lesions, and other brain regions
(GM and CSF) as background samples. As above, equations (4.8), (4.9) and (4.7) are
calculated and used to guide the propagation of the level set surface. The result is an
estimate of the NAWM region, XNAWM .
Segmentation of MS lesions We estimate the MS lesion region as the difference
between AWM and NAWM:
XMS = XAWM −XNAWM . (4.10)
As would be expected with most subtractive techniques, some voxels along the
boundaries between tissues may be included in the MS lesion results (false positives).
These voxels normally form disconnected small objects, which are removed by a
morphological opening operation with a radius of 1 voxel.
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4.2.4 Algorithm Evaluation
We evaluated our method on two public, freely available MS lesion datasets: the
BrainWeb synthetic phantom data (Cocosco et al., 1997), and the 2008 MS lesion
segmentation challenge data (Challenge08) (Styner et al., 2008).
BrainWeb phantom The BrainWeb Simulated Brain Database provides MRI
phantoms with three different MS lesion loads: mild, moderate, and severe. Each
phantom contains T1w, T2w, and proton density weighted (PDw) spin-echo MRIs.
Also included is a ground truth, voxel-by-voxel, tissue label map. In addition, different
noise and inhomogeneity levels can be simulated and added to the images.
Our algorithm was applied to T1w and T2w MRIs with a noise level of 3% and an
intensity inhomogeneity of 0%, without any preprocessing. RF inhomogeneity was
not varied due to the availability of effective approaches for bias correction. Two
sets of seed points were placed by one user to obtain the MS lesions in each mild,
moderate, and severe case. The curvature tuning parameter α was set to 0.12 by
default (Xue et al., 2014). The segmentation accuracy was evaluated relative to the
ground truth by computing the Dice similarity coefficient (DSC), a measure of spatial
overlap ranging from 0 to 1, with 1 indicating perfect overlap. Then the DSCs were
compared to the DSC reported by Garcia-Lorenzo et al. (García-Lorenzo et al., 2009),
the top performing algorithm in Challenge08.
We observed that the ground truth of BrainWeb data contains very small lesions,
with just a few voxels each. Therefore, we also computed the lesion detection rate
(LDR) for the BrainWeb phantoms, where LDR is the DSC based on the overlap of
detected lesions rather than voxels. A lesion was considered “detected" if any of its
voxels were labeled as lesion in the segmentation. Assessing our algorithm’s ability
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to detect at least some portion of a lesion, in addition to all lesion voxels, separates
the task of lesion identification from the task of volumetric segmentation. In effect,
LDR assigns a greater penalty to missing (or erroneously adding) a small lesion than
missing (or adding) a small region of pixels on an otherwise successfully identified
lesion.
The LDR was computed only for lesions greater than four voxels in volume as
smaller lesions were eliminated, along with some noise and artifacts, in the morphologi-
cal opening step. We rationalized this decision after consulting with an MS neurologist
at our institution (DW). Lesions consisting of 4 voxels or less are rarely measured in
clinical practice. For example, there were no lesions this small in the expert manual
labels provided with Challenge08 data.
Patient images Challenge08 (Styner et al., 2008) provides 20 training cases,
half from the Children’s Hospital of Boston (CHB) and half from the University of
North Carolina (UNC). Each case contains T1w, T2w, and FLAIR MRI. This data is
provided with the following preprocessing steps performed: brain extraction, intensity
inhomogeneity correction, and intensity re-scaling (to 8-bit unsigned integer). Manual
labels of the MS lesions by one expert (from CHB) are provided and were used as
truth in algorithm evaluations. Our algorithm was provided with the T2w and FLAIR
MRI for MS lesion segmentation. Addition of the T1w images did not improve our
results (data not shown).
For each case, three sets of seed points (described above) were placed by one user
(WX) and saved for repeated use. We then performed a 5-fold cross validation of our
algorithm as in Brosch et al. (Brosch et al., 2015). Briefly, each case was randomly
assigned to one of 5 groups. The first 4 groups were used to train our algorithm
(details below). Then the trained algorithm was applied to the last "test" group, and
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the results obtained. This process was repeated 5 times, selecting a different test
group each time. At each step the segmentation accuracy was evaluated relative to
the expert manual labels by computing the average values of the true positive rate
(TPR), positive prediction value (PPV), and DSC across the 4 cases in the test group.
Our results were compared to the results reported by Geremia et al. (Geremia et al.,
2011) and Brosch et al. (Brosch et al., 2015). The execution time required to segment
each test case was also recorded. These times were then averaged across all 5-folds of
the cross validation to determine the overall mean execution time.
Algorithm training consisted of identifying optimal values for α in equation (4.2)
for AWM and NAWM using a procedure described previously (Xue et al., 2014). We
refer to these as αAWM and αNAWM , respectively. Briefly, for each tissue α was varied
from 0.05 to 0.45 with a step size of 0.1. The pair (αAWM , αNAWM) that maximized
the DSC for XMS was retained and applied to the test group of cases. Importantly,
the training data provides guidance for parameter settings in this application. The
user can make adjustments and the algorithm does not require a training step (unlike
(Brosch et al., 2015)).
4.3 Results
BrainWeb phantoms The DSC of our method is presented and compared to
(García-Lorenzo et al., 2009) (Table 4). Our method had a lower DSC on MRIs with
mild lesion load, but a higher DSC on cases with moderate and severe lesion load.
DSC and LDR for both unaltered and small-lesion (4 voxels or less) removed versions
of truth are also presented (Table 5). Eliminating small lesions from the ground truth
had a small positive impact on DSC, but increased the average LDR of our method
from 0.70 to 0.89. In other words, our method detected 89% of the MS lesions larger
than 4 voxels, on average.
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Figure 11. Close up comparison between the true MS lesion distribution and our
algorithm’s estimated MS lesion distribution. This is the same representative slice
depicted in Fig. 10, and is from the BrainWeb phantom with moderate lesion load.
True positive voxels are blue; false positive voxels are green; and, false negative voxels
are red.
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Table 4. Comparison of DSC on BrainWeb data
Mild Moderate Severe
Garcia09 .67 .72 .76
Our method .55 .74 .81
Patient images Mean α values and execution times from algorithm training
during the 5-fold cross validation are shown in Table 6. The relationship between the
pair of values (αAWM , αNAWM ) and overall DSC for XMS is shown in Fig. 12 for each
contributing imaging center (CHB and UNC).
Results from the algorithm evaluation are shown in Table 7, and compared to
published results from two leading algorithms. Our algorithm had a higher TPR
and DSC than the comparison algorithms, and a PPV nearly half way between these
algorithms.
Table 5. DSC and LDR (lesion detection rate) of our method on BrainWeb data
Mild Moderate Severe
Based on unaltered truth DSC .55 .74 .81
LDR .67 .69 .74
Truth wo/ small lesions DSC .55 .75 .82
LDR .88 .84 .94
Table 6. Algorithm training results. α is dimensionless. Execution time is in seconds.
Value shown is the overall mean (± standard deviation) from the 5-fold
cross-validation.
α Execution Time
AWM 0.45 (± 0.0) 12.47 (± 3.19)
NAWM 0.075 (± 0.05) 8.33 (± 4.40)
Total – 20.80 (± 5.43)
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Figure 12. Graph of the dice coefficient (accuracy, vertical axis) for XMS for various
(αAWM , αNAWM) combinations. High values for αAWM and low values for αNAWM
produced the highest accuracy. This observation applied equally to the data from
both centers.
Table 7. Comparison of the results with other methods.
Method TPR PPV DSC
Geremia et al. (Geremia et al., 2011) 39.85 40.35 –
Brosch et al. (Brosch et al., 2015) 39.71 41.38 35.52
Our method 44.33 40.79 38.88
4.4 Conclusion
We developed a new method to segment MS lesions in multi-spectral MRI exams.
Our approach leverages the speed of a GPU level set algorithm to perform multiple
segmentations of brain white matter in each MRI exam. Changes in level set initial-
ization parameters between iterations allow us to estimate the distribution of white
matter lesions. A new data term in the level set speed function eliminates the need to
store MRI exams on the GPU memory. Instead, a fixed size data and seed dependent
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lookup table is employed. This allows multi-spectral MRI exams that are too large to
fit on the GPU memory to be processed efficiently using our algorithm.
The proposed method was evaluated on BrainWeb and Challenge08 data and
achieved results comparable to, or better than, two leading algorithms. The average
execution time for our algorithm to segment lesions in Challenge08 data was 20.8
seconds. Current limitations include the need for a user to seed three regions in each
exam: NAWM; GM and CSF (major brain anatomy); and, one or more MS lesions.
Future work will focus on automating the seed placement step using statistical and/or
atlas-based co-registration approaches. Finally, better post-processing methods may
reduce false positive lesions.
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Chapter 5
RETROSPECTIVE VALIDATION OF A COMPUTER ASSISTED
QUANTIFICATION MODEL OF INTRACEREBRAL HEMORRHAGE VOLUME,
COMPARED TO ABC/2 METHOD
In this chapter, we report a retrospective clinical validation study to evaluate
our method on a larger clinical dataset. This study presents a general framework
to comprehensively validate medical image segmentation tools in clinical setting.
Four clinicians performed intracerebral hemorrhage volume measurements. The bias,
precision, and measurement time were calculated based on the results, and compared
to ABC/2 method (the common clinical practice). Note that in this manuscript, we
name our application SegTool, which refers to the user interactive application with
graphical user interface.
My contributions in this manuscript are 1) making the changes of underlying
algorithm and front-end graphical user interface of our application for ICH study, 2)
training all operators, 3) collecting and cleaning the volume data after the measure-
ments 4) drafting abstract, methods, and results and creating three of the four figures.
Note that Dr Vegunta is co-first author, contributing on the clinical side of this study.
This manuscript is submitted to American Journal of Neuroradiology.
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Aguilar4, Ameet C. Patel3, Joseph M. Hoxworth3, Bart M. Demaerschalk4, and J.
Ross Mitchell5
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Abstract Background and Purpose: Intracerebral hemorrhage accounts for 6.5%
to 19.6% of all acute strokes. Initial hematoma volume and expansion are both inde-
pendent predictors of clinical outcomes and mortality. Therefore, a rapid, unbiased and
precise measurement of hematoma volume is a key component of clinical management.
The most commonly used method is ABC/2, which results in overestimation. We de-
veloped a custom user interactive segmentation program, SegTool, using a novel GPU
level set algorithm. Until now the speed, bias, and precision of SegTool had not been
validated. Methods: In a single stroke academic center, two vascular neurologists and
two neuro-radiologists independently performed a test-retest experiment that involved
repeated measurements of static, unchanging ICH volumes on CT on 76 ICH cases.
Measurements were made using both SegTool and the ABC/2. True ICH volumes
were estimated using a consensus of repeated manual tracings by two operators. These
data allowed us to estimate measurement bias, precision and speed. Results: The
measurements with SegTool were not significantly different compared to the true ICH
volumes, while ABC/2 overestimated volume by 45%. The inter-rater measurement
variability with SegTool was 50% less than with ABC/2. The average measurement
times for ABC/2 and SegTool were 35.7s and 44.6s, respectively. Conclusion: SegTool
appears to have attributes superior to ABC/2 in terms of accuracy and interrater
reliability without a significant delay in acquisition time, hence it could be useful in
clinical practice and clinical trials.
Keyword: intracerebral hemorrhage, stroke, image quantitative, CT, radiology
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5.1 Introduction
Spontaneous, nontraumatic intracerebral hemorrhage (ICH) implies bleeding into
the brain parenchyma that may extend into the ventricular system and/or subarachnoid
space. ICH is the cause of 6.5%-19.6% of all strokes (Feigin et al., 2000). ICH has
an estimated annual incidence of 12-15 per 100,000 in the USA (Woo et al., 1990)
and 15.9 per 100,000 worldwide (Sacco et al., 2009). After ICH, active bleeding may
continue for hours (T et al., 1997). Mortality has been reported to be approximately
31%-34% at 7 days and 53%-59% at 1 year (Flaherty et al., 2006).
Signs and symptoms of ICH are nonspecific; therefore, neuroimaging is mandatory
for diagnosis (Goldstein, 2005). Computed tomography (CT) is sensitive for identifying
acute hemorrhage and is considered the gold standard (Morgenstern et al., 2010).
28%-38% of patients undergoing head CT within 3 hours of ICH onset have hematoma
expansion of greater than one third on follow-up CT (T et al., 1997). Initial hematoma
volume and rate of growth are both independent predictors of clinical outcomes
and mortality (Davis et al., 2006). Attenuation of growth is an important treatment
strategy (Davis et al., 2006). Consequently, a rapid, unbiased and precise measurement
of hematoma volume is an important component of clinical management.
There are a variety of methods to measure the volume of a hematoma. Common
methods of lesion volume measurement are equations for a sphere, ellipsoid, or
rectangular piped. The equations are applied to a lesion according to the reader’s
interpretation of the lesion shape. The most commonly used equation is the simplified
ellipsoid formula (ABC/2) (Divani et al., 2011), “where A is the greatest hemorrhage
diameter by CT, B is the diameter 90 degrees to A, and C is the approximate number
of CT slices with hemorrhage multiplied by the slice thickness.” (Kothari et al., 1996)
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Use of this formula often results in large volume estimation errors, particularly for
large or irregularly shaped objects (Divani et al., 2011; Wang et al., 2009).
There is significant interest in semi-automatic computer models that can offer
fast, low-bias, and precise lesion volume measurements (Kosior et al., 2011). Among
computer-based models, level set algorithms (Osher and Sethian, 1988b) have become
a widely used method of determining lesion, organ, and bone volumes in recent years
(Anandh et al., 2014; Ivanovska et al., 2016).
Semi-automatic segmentation algorithms are generally user ’seeded’. The reader
places a seed on the image that triggers segmentation of an associated region of
interest. Level set algorithms grow a seed placed within the region of interest based
on pixel intensity to cover the entire lesion. Several parameters including the rate of
growth and curvature of the segmented surface are controlled by local image properties
and can also be adjusted by the reader (Whitaker, 1994). Level set algorithms are
robust and flexible and prevent growth of the seed across weak, incidental connections
into areas outside the lesion (Roberts et al., 2010).
For example, Cates et al. (Cates et al., 2004) demonstrated in a study of 9
meningioma or low grade glioma MRI images, that level set volume measurements
produce results that are similar to those from hand tracings. Colliot et al. (Colliot
et al., 2006) found that measurement bias was low when they used level sets to measure
cortical dysplasia lesions on MRI in 18 patients. Similarly, Saba et al. (Saba et al.,
2014) obtained a low bias using level sets to measure carotid artery wall thickness
on MRI’s of 10 patients; the level set volumes were compared to volumes calculated
using manual tracings in both studies.
Level set algorithms require an enormous number of computations, consequently,
being often too slow for practical clinical applications. To address this, we previously
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developed a novel level set algorithm that leverages the massive parallelism of com-
modity graphical processing units (GPUs) (Roberts et al., 2010). This algorithm is 14
times faster than the fastest previously reported parallel algorithm, and hundreds of
times faster than serial algorithms on current central processing units. The algorithm
had low bias and variability when segmenting tissues in a realistic brain phantom,
an anatomically accurate three dimensional simulation of the human brain. Dang
et al. (Dang et al., 2013) reported that its speed, bias, and precision in measuring
meningioma volume are superior to modified McDonald criteria and manual outlining
on 25 contrast enhanced MR exams. However, the speed, bias, and precision of level
set algorithms have not been tested using a large sample size of ICH and multiple
clinician readers.
In this study, two vascular neurologists and two neuro-radiologists independently
performed a test-retest experiment that involved repeated measurements of static,
unchanging ICH volumes on CT. Measurements were made using both the level set
algorithm and the ABC/2. We also estimated true ICH volumes using a consensus
of repeated computer-assisted manual tracings (planimetrics) by one neurologist and
one neuro-radiologist. Together, these data allowed us to estimate measurement bias,
precision and acquisition time. To the best of our knowledge, this is the first time all
three of these clinically relevant characteristics of ICH volume measurement have been
estimated, analyzed and reported together. Bias and precision estimates presented
here may aid to the design and execution of future clinical trials.
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5.2 Methods
After IRB review, images for this study were obtained from an existing database of
hemorrhagic stroke cases presenting to Mayo Clinic Hospital in Arizona between (date)
and (date). Seventy-six cases with CT imaging available and noted intraparenchymal
hematomas were selected. Exclusion criteria included extracerebral hemorrhage
including intra-ventricular hematoma. Six cases were randomly withheld from the
experimental dataset and used for training purposes.
Four operators, two neuro-radiologists and two vascular neurologists, collected level
set and ABC/2 measurements in this study using custom developed GPU level set
software [] and Osirix (Pixmeo, Geneva, Switzerland) respectively. The 70 non-training
cases were each measured twice, by four operators, using both methods, for a total
of 1120 measurements (70 cases x 4 operators x 2 methods x 2 repeats). One of the
neurologists and one of the neuro-radiologists also manually outlined lesions using
Osirix (70 cases x 2 operators x 2 repeats) in order to estimate true lesion volumes
(described below).
In order to limit learning effects, repeated measurements of all cases in random
order occurred after a minimum two-week delay. Manual tracings were done first
followed by ABC/2 and finally level set. An additional level set correction process
was introduced after initial data analysis. Figure 1a reviews the workflow for both
the ABC/2 and level set measurement processes.
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Figure 13. Hemorrhage measurement methods. A) a flowchart describing steps in the
ABC/2 and level set measurement processes. b) Results from the ABC / 2 method; c)
Results from the level set method. Green and red strokes were placed by the user.
Green indicates desired tissue (foreground) and red indicates undesired tissue
(background). The level set region grows in 3D after the user clicks “Go” (Figure 2);
and, d) Manual outlining of the boundary in a single axial slice. This process was
replicated in each axial slice with visible ICH. Each true volume was determined from
4 manual tracings – two operators each performed two repeated manual tracings. A
minimum interval of 1 week between repeated tracings was required. Any voxel
selected in at least 3 of the 4 manual tracings was labeled a “true” lesion voxel, and
used to estimate the true lesion volume.
5.2.1 ABC/2 Method
The operator identified the axial slices with the largest lesion extent, then measured
the two longest orthogonal diameters of the lesion using OsiriX ROI length tool (Fig
1b). The lesion volume was estimated as:
Lesion volume =
A×B × C
2
,
where A and B are the length of the two diameters, and C is slice thickness multiplied
by the number of slices where lesion was visible.
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5.2.2 Level Set Method
The operator drew one or more green strokes in the object(s) to be segmented
(ICH in our experiments), and one or more red strokes in surrounding tissue they
did not want to include (surrounding brain parenchyma in our experiments). Strokes
were placed on 2D axial slices (Fig 1c and Fig 2a). The operator then clicked a “Play”
button to initiate object growth. Growth occurred in real-time and could be visualized
in two or three dimensions interactively (Fig 2b-c). The algorithm naturally handles
the simultaneous growth, merging, and separation of multiple distinctly seeded regions.
The surface propagation was guided by a K nearest neighbor (KNN) statistical
model of the intensity values provided by the seed points, and a curvature parameter
between 0 and 1 that determined the surface stiffness. In all cases the curvature
parameter was initialized to 0.25. During, or following, region growth, the operator
could adjust a slider to manipulate the curvature parameter. Higher values encouraged
smoother, smaller volumes. Lower values encouraged larger, more irregular volumes.
The effects of changes in the curvature parameter on the segmented volume occurred
and were displayed in real-time.
The user had the ability to then review the segmentation in 2D, or in 3D by
rotating the CT scan volume (Fig 2d). After the user accepted the results, the
application calculated and recorded the ICH volume, operation time, and binary mask
(segmentation) of the ICH.
A common issue in level set segmentation is ‘leakage’. Artificial connections
between blood and bone (both bright on CT) can be caused by partial volume effects
between hemorrhage and skull (due in part to the large slice thickness of clinical
image exams). This can be corrected either by increasing the level set surface stiffness
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Figure 14. The level set ICH segmentation process in a CT scan with a 512 x 512 x
36 array. (a) The user placed foreground (green) and background (red) seeds in an
axial slice (Figure 1c). Here the seeds are viewed in 3D. After the user clicks the “Go”
button (not shown), the level set evolves to cover the ICH. In this example, a 41 ml
ICH is segmented in 3 seconds (b-c). The final segmented region can be viewed in 2D,
or in 3D by rotating the CT scan volume (d).
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(causing the leak to retract back into the segmented region), or by removing the leaked
regions with editing tools.
Accordingly, after all measurements were completed, the level set results were tested
for outliers using the inter-quartile range outlier-labeling rule23. This test indicated
that 24 / 560 measurements (4.3%) in 19 / 70 patients (27.1%) could be considered
outliers (data not shown). It was determined that the default transparency level of the
segmented region was such that operators found it difficult to detect leaks into bone
(Figure 3a). Consequently, we asked all operators to perform a review of all of their
level set measurements with the suggested workflow that they reduce the transparency
of the green region until it was opaque and then review their measurements in 3D
(Figure 3b). Readers were permitted to correct any segmentation either by editing or
starting over. Both the initial and ‘after review’ level set measurements were recorded
and compared to ABC/2 method.
5.2.3 True ICH Volume Estimation
The true ICH volume was estimated from manual tracings. One neurologist and
one neuro-radiologist operator each independently manually traced the lesion on each
axial slice in which it was apparent using the ROI pencil tool of OsiriX (Fig 1d).
OsiriX was used to calculate the area in each slice and the lesion volume was calculated
as:
Lesion volume = slice thickness× summation of lesion areas of all slices.
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Figure 15. The level set algorithm may leak. An axial (a) and 3D view (b) of one
segmented ICH lesion (enclosed in a red ellipse) along with level set leakage outside of
the lesion. Leakage was caused by partial volume effects between hemorrhage and
skull (due in part to the large slice thickness of the clinical imaging exams). This can
be corrected either by increasing the level set surface stiffness, or by removing the
leaked regions with editing tools. However, when the transparency of the segmented
(green) region was high (as it was by default), operators found it difficult to detect
leaks. Consequently we asked all operators to perform a blinded review of their level
set segmentations. They performed this by interactively reducing the transparency of
the green region until it was opaque, then viewing their segmentation in 3D (b). If,
for any reason, they were unsatisfied with the labeled region, they were asked to
re-segment the lesion. In the text we describe several enhancements to the tool that
could be made to help operators detect leaks prior to saving the final segmented
region.
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Each true volume was estimated from four manual tracings by the two operators. Any
voxel selected in at least three of the four manual tracings was labeled a “true” lesion
voxel, and used to estimate the true lesion volume.
5.2.4 Statistical Analysis
We used methodology recommended by the Quantitative Imaging Biomarker
Alliance to assess the uncertainty in volume measurement. In particular, we used a
disaggregate approach to express uncertainty in terms of bias and precision. They
define bias as “the difference between the average (expected value) of measurements
made on the same object and its true value.” They define precision as “the closeness
of agreement between measured quantity values obtained by replicate measurements
on the same or similar experimental units under specified conditions.”
Precision is related to the variability in volume measurement. There are several
ways it can be described numerically. Here, we chose to express precision as a clinically
relevant threshold: the 95% minimum detectable change24 (MDC). Magnitude changes
in volume ≤ to the MDC can be explained by variability in the measurement process
alone, with 95% confidence. Therefore, magnitude changes in volume >MDC can be
ascribed to lesion growth (or shrinkage) with a type II error rate of 5%.
We used a two-way random-effects analysis of variance (ANOVA) as previously
described (Eliasziw et al., 1994; Mitchell et al., 1996), to estimate between- and within-
operator variability for both measurement methods. These values were then used to
calculate the between- and within-operator MDC for each method. The measurement
bias of each method was determined by comparing the mean measured ICH volume
to the estimated true ICH volume. The measurement time of the ABC/2 method was
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determined by timing the readers as they measured the volumes. The measurement
time of the level set method was recorded directly by the program.
5.3 Results
Summary statistics for our experiments are presented in the Table. The ABC/2
method produced larger volume estimates than the level set method. Level set mea-
surements, after review, were smaller on average than the initial level set measurements.
Operators modified 140 (of 560) level set measurements during the review process.
Table 8. Summary statistics for our experiments. All values are in mL, except N that
is dimensionless. The values in the Level set (revisions) column indicate the change
after operators reviewed their initial measurements. Negative values mean the
after-review value was smaller than the initial value.
ABC/2 Level set(initial)
Level set
(after review)
Level set
(revision)
N 560 560 560 140
Mean (std. dev.) 35.28 (56.24) 26.02 (40.35) 25.32 (39.76) -2.2 (12.7)
1st Quartile 7.00 4.77 4.84 -1.43
Median 18.48 13.19 13.09 -0.01
3rd Quartile 36.82 28.87 27.47 0.40
Figure 4 shows the measurement bias (a), precision (b), and time (c) for the ABC/2
and level set (after review) methods. On average, the ABC/2 and level set methods
produced measurements that were 45% and 3% larger than truth, respectively. (The
slope of the line of best fit for ABC/2 and level set was 1.45 and 1.03, respectively.)
The slope of the line of best fit for level set was not statistically different than 1.0,
the line of perfect agreement between measured and true volumes (p > 0.05).
Between-operator MDC for ABC/2 was 13.94 mL. This was significantly higher
(worse) than level set MDC before (11.93 mL, p < 0.02) and after (9.51 mL, p < 0.02)
the operators reviewed for level set leakage.
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Figure 16. The: (a) bias; (b) precision; and, (c) time for ICH volume measurement.
Measurements made using the ABC/2 method are shown in red. Those made using
the level set are shown purple (initial) or blue (after review). (a) Bias: the dashed
(purple) line indicates perfect agreement between measured and true volumes. Each
true volume was determined from 4 manual tracings placed by experts (details in the
text). The solid markers indicate the mean measured volume determined from 8
measurements (4 operators x 2 measurements / operator). The error bars indicate
the 95% confidence interval for the mean measured volume. The solid lines show a
linear regression fit through all measurements for each method. The shaded zone
around each solid line indicates the 95% confidence interval for the slope of the line.
Each line is labeled with its equation, the p-value from the linear regression, and the
Coefficient of Determination describing goodness of fit (1.0 equals a perfect fit). (b)
Precision: lower values are better. Changes in ICH volume less than the indicated
value can be explained by measurement variability alone, with 95% confidence. The
values in the “Between Operator” group are all statistically significantly different (p <
0.02). The “Level Set (initial)” value in the “Within Operators” group is significantly
different than the other values (p < 0.001), which are not significantly different from
each other (p = 0.8). (c) Time: each bar indicates the mean value from 560
measurements (70 ICH lesions x 4 operators x 2 repeated measurements). The error
bars indicate the standard error of the mean. On average, the Level Set required an
extra 8.9 seconds to measure ICH volume. This difference is statistically significantly
different from 0 (p < 0.0001).
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Within operator MDC for the ABC/2 method was 7.47 mL. This was significantly
lower than the MDC for the initial group of level set measurements (9.93 mL, p <
0.001). However, after the operators reviewed and revised their level set measurements
to eliminate leaks, level set MDC improved to 7.37 mL. This value was not statistically
significantly different than the ABC/2 MDC (p = 0.8).
Measurement time is the total time required to complete the steps listed in Figure
1 (a), after the data was loaded. The average measurement times for the ABC/2
and level set (initial) methods were 35.7 s and 44.6 s, respectively. The average
measurement time for repeating the level set measurements (after review) was not
statistically significantly different than the average initial measurement time (data
not shown). The level set method took an extra 8.9 seconds to complete, on average.
This difference was significantly different from 0 (p < 0.0001).
5.4 Discussion
5.4.1 ICH Measurement Bias
To determine bias, true lesion volumes are required. These are often unknown
in clinical experiments. A compromise is to estimate the true volume of each lesion
using a consensus of expert segmentations in medical images. In our experiments,
true ICH volume was estimated by a majority-voting scheme. A voxel was considered
part of the true ICH if it was selected in at least 3 of 4 manual tracings performed by
experts (two operators each performed two manual tracings of each lesion). Other
schemes are also possible (Kessler et al., 2015).
Several studies have reported that baseline ICH volume is highly predictive of
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30-day morbidity and mortality (Broderick et al., 1993; Hemphill et al., 2001). It is
also well acknowledged that the ABC/2 method tends to overestimate lesion volumes
(Xu et al., 2014; Webb et al., 2015). In our study, the ABC/2 method overestimated
ICH volume by 45%, on average. On the other hand, the mean level set measurements
were no different than the estimated true ICH volumes. The low measurement bias
of the level set algorithm could be important for future clinical trials that rely on
baseline ICH volume for patient stratification.
5.4.2 ICH Measurement Precision
There was no significant difference in the within operator MDC between the ABC/2
and level set method (after review to check for leaks). However, the level set method
had between operator MDC that was approximately 50% lower (better) than the
ABC/2 method. This is important, since in many clinical scenarios it is difficult to
ensure that a single individual performs all volume measurements.
A recent study by Dowlatshahi et al. (Dowlatshahi et al., 2011) reported that
hematoma expansion of 33% or 12.5 mL was highly predictive of poor outcome.
The between-operator MDC of the ABC/2 method in our study was 13.94 mL.
Consequently, an expansion of up to 13.94 mL measured this way can be explained by
measurement variability alone (with 95% confidence) and may not correspond to true
hematoma growth. The level set method, on the other hand, had a between-operator
MDC of 9.51 mL. An expansion of 12.5 mL measured this way is too large to be
explained by measurement variability alone. Consequently, it may be ascribed to ICH
growth.
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5.4.3 Comparisons to Previous Studies
A number of previous studies have compared the ABC/2 method to one or more
computer-assisted methods for measuring ICH volume. For example, Divani et. al.32
compared ABC/2 to planimetric measurements made with MIPAV (NIH, Bethesda,
MD) and to computer assisted segmentation using Analyze (Analyze Direct, Overland
Park, KS) and Voxar 3D (Barco NV, Belgium). Their study focused on determining
measurement bias. Measurements were made from a silicone phantom, and from
simulated lesions implanted in cadaver brains. A variety of CT protocols were used.
They found that ABC/2 produced large over estimations of lesion volume. They did
not report measurement precision or time.
Freeman et al. (Freeman et al., 2008) compared ABC/2 to Analyze in a series
of 8 ICH patients treated with Warfarin. They used the Analyze measurements to
estimate true lesion volumes. These were then used to estimate the measurement bias
of ABC/2. They concluded that ABC/2 has small measurement bias for small lesions,
but can produce large errors (both over and under estimation of true volume) for
large or complex lesions. They did not exhaustively examine measurement time, but
reported that the most accurate method of measuring lesion volume with Analyze
required 20 – 30 minutes per study, after a steep learning curve. They did not report
measurement precision.
Xu et. al. (Xu et al., 2014) compared ABC/2 to computer-assisted measurements
made using an intensity threshold algorithm in 3D Slicer (www.slicer.org) in 294 CT
exams. Two physicians each made a single measurement of each lesion using each
method. They used the Slicer measurements to estimate true lesion volumes. These
were then used to estimate the measurement bias of ABC/2. They also divided the
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lesions into groups based on size and shape, and compared the two measurement
methods between groups. They concluded that ABC/2 over estimated lesion volumes,
and that these errors increased with lesion volume, and with more complex shape.
They reported that the average time required to measure lesion volume with 3D Slicer
was 96 seconds. They did not report measurement precision or ABC/2 measurement
times.
Kosior et al. (Kosior et al., 2011) compared ABC/2 to computer-assisted mea-
surements made using custom-developed software (Quantomo) that used an intensity
threshold algorithm available as part of the Insight Segmentation and Registration
Toolkit (ITK, NLM / NIH, Bethesda, MD). Kosior’s study was focused on evaluating
measurement precision. Like our study, they used a test-retest experiment and a
two-way random-effects ANOVA to determine MDC for each method. They also had
4 operators each perform 2 repeated measures using each measurement method. They
reported the within-operator MDCs for ABC/2 and Quantomo as 15.7 and 5.3 mL,
respectively (vs. our values of 7.47 and 7.37 for ABC/2 and level set (after review),
respectively). Their reported between-operator MDCs for ABC/2 and Quantomo were
37.0 and 8.1 mL, respectively (vs. our results of 13.94 and 9.51 mL, respectively).
There were several differences between their methods and ours. These include: 5
days between repeated measures (vs. 2 weeks in our study); and, measurement of 30
CT scans (vs. 70 in our study). It is also likely that their CT scan protocol was more
consistent between patients than ours, since their patients were recruited from a clinical
trial whereas ours were recruited from our general patient population over several
years. Another potential difference: in Kosior’s paper, all of the cross-sectional images
of the brain do not have a visible skull, suggesting that a skull-stripping algorithm may
have been used as a pre-processing step. The paper does not mention the presence
66
or absence of any pre-processing steps, however. CT scans in our study had no
pre-processing performed. Skull-stripping, if applied, should reduce the variability of
computer-assisted volume measurement by reducing the likelihood of leaks or growth
from ICH into partial volume voxels that overlap blood and skull. Finally, they did
not report measurement bias or times.
5.4.4 Level Set Leaks
One of the weaknesses of our study was the need to have operators review their
initial level set measurements. This was performed in a blinded fashion – operators
were not provided with any information on which studies may have had leaks. They
were free to redo or edit any, all or none of their prior measurements. In total, 140
of the initial 560 segmentations were revised. The median result was to reduce the
lesion volume by 0.01 mL. The mean effect was to reduce lesion volume by 2.2 mL.
The impact on measurement precision was to reduce between-operator MDC from
11.93 to 9.51 mL, and to reduce within-operator MDC from 9.93 to 7.37 mL.
There are several modifications we could make to the measurement process to
increase the visibility of level set leaks and/or reduce their likelihood. By default, the
segmented region was highly translucent. This made level set growth into brightly
saturated bone very difficult to see. Simply increasing the default opacity of the
segmented region would address this limitation.
Next, we could place “high water” and “low water” indicators on the slider controlling
surface stiffness. This would provide visual feedback to operators about the range
over which they have adjusted surface stiffness during the current region growing
process. This would help operators identify parameter values that allowed leakage to
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occur. Increasing surface stiffness slightly causes the leaked region to quickly retract
into the main body of the segmented region. The operator would then be able to
lower stiffness to a point just above the “low water” mark on the slider to achieve an
acceptable segmentation, without leaks.
We could also add an independent visual cue to indicate the size of the segmented
(green) region, relative to the size of the image volume (or the size of all non-background
voxels in the volume). Imagine, for example, a display showing a scaled down 3D
representation of the segmented region embedded within a larger translucent cube
(representing the image volume). The size of the embedded region could change,
interactively, in proportion to the size of the segmented region. This would provide
operators a visual indication of the size of the segmented region relative to the size of
the image volume, without having to explicitly switch to a 3D view of the dataset or
adjust the opacity of the segmented region.
Finally, we could also pre-process the image volumes to strip skulls. Several
open-source algorithms are available to perform this task. This would cause delays in
interpretation however.
5.5 Conclusion
Although an ICH volume measurement with the SegTool took 9 s longer to complete
on average, compared with the traditional ABC/2 method, the SegTool was superior in
all other clinically relevant aspects. The SegTool ICH volumetric measurements were
not significantly different than the true ICH volumes, while ABC/2 overestimated ICH
volume by 45%. The between-operator measurement variability with the SegTool was
50% less than with ABC/2. The SegTool was capable of detecting minimal clinically
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important differences in ICH volume, whereas the ABC/2 was not. The SegTool
appears to have measurement attributes superior to ABC/2 method and could be
useful in clinical trials and clinical practice when intervention and prognostication rely
upon accurate baseline ICH volume or upon detecting change in serial ICH volumetric
measurements.
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Chapter 6
DISCUSSION
This application obtains quantitative information from medical images. It extracts
meaningful information and knowledge from unstructured medical imaging data
and pave the way for further medical image analysis and decision making, which
is the next step within biomedical imaging informatics. For instance, computer
aided diagnosis (CAD) systems could use this information as input to help the
physicians provide personalized patient care. Furthermore, researchers from other area
of biomedical informatics could combine this quantitative image information with their
own information to conduct research or make clinical decisions. For instance, along
with genome data, this could be used to discover the correlation between radiology
and genomics, potentially revolutionizes the bioinformatics field. In addition, clinical
decision making systems could use this application and nature language process tools
to better utilize the all kinds of data from electronic medical records (EMR). Last
but not the least, when using the EMRs of a large population, it could be used to
determine and discover screening methods so that abnormalities could be detected
earlier.
6.1 Potential Impact on Clinical Practice
In Chapter 5, I compared this application with the standard ABC/2 method to
measure ICH stroke volumes. The standard ABC/2 method is the most commonly
used clinical method to estimate stroke volume, “where A is the greatest hemorrhage
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diameter by CT, B is the diameter 90 degrees to A, and C is the approximate number
of CT slices with hemorrhage multiplied by the slice thickness.” Use of this equation
often results in significant volume estimation errors, particularly for large or irregularly
shaped objects. RECIST simplifies the ABC/2 method by measuring only one length
(A) of up to 5 lesions from images, but applied to solid tumor size measurements.
6.1.1 Bias
True lesion volumes are required to determine bias. These are often unknown in
clinical experiments. One compromise is to estimate the true volume of each lesion
using a consensus of expert segmentations in medical images. In the experiments,
true ICH volume was estimated by a majority-voting scheme. A voxel was considered
part of the true ICH if it was selected in at least 3 of 4 manual tracings performed by
experts (two operators each performed two manual tracings of each lesion). Other
schemes are also possible.
Several studies have reported that baseline ICH volume is highly predictive of
30-day morbidity and mortality. It is also well acknowledged that ABC/2 tends
to overestimate lesion volumes (Xu et al., 2014; Webb et al., 2015). In this study,
ABC/2 overestimated ICH volume by 45% on average. In contrast, the mean of this
application measurements were no different than the estimated true ICH volumes.
The low measurement bias of this application could be important for future clinical
trials that rely on baseline ICH volume for patient stratification.
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6.1.2 Precision
There was no significant difference in the within-operator minimum detectable
change (MDC) between ABC/2 and this application. However, this application had
a between-operator MDC that was approximately 50% lower (better) than ABC/2.
This is important because in many clinical scenarios it is difficult to ensure that a
single individual performs all volume measurements.
A recent study by Dowlatshahi et al. (Dowlatshahi et al., 2011) reported that
hematoma expansion of 33%,or 12.5 mL, was highly predictive of poor outcome. The
between-operator MDC of ABC/2 in the study was 13.94 mL. Consequently, an
expansion of up to 13.94 mL measured this way can be explained by measurement
variability alone (with 95% confidence) and may not correspond to true hematoma
growth. This application, on the other hand, had a between-operator MDC of 9.51
mL. An expansion of 12.5 mL measured this way is too large to be explained by
measurement variability alone. Consequently, it may be ascribed to ICH growth.
6.1.3 Acquisition Time
The average measurement times for ABC/2 and this application were 35.7 s and
44.6 s, respectively. This application required an extra 8.9 seconds on average to
complete measurements. The 9 seconds delay could be explained that the operators
use ABC/2 method much more regularly in their clinical practice, while only used
this application to measure volumes after one to two weeks training. Nonetheless, it
is still much faster than the manual delineation or other computer-assisted methods.
Freeman et al. (Freeman et al., 2008) compared ABC/2 to Analyze software in a
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series of 8 ICH patients treated with Warfarin. They did not exhaustively examine
measurement time, but reported that the most accurate method of measuring lesion
volume with Analyze required 20 – 30 minutes per study, after a steep learning curve.
6.1.4 Future Work
6.1.4.1 Translation to iCORE Lab in Radiology
One of the places which could benefit from this application is the imaging Clinical
Outcomes and Response Evaluation (iCORE) Lab at Mayo Clinic Arizona. iCORE
provides comprehensive image management, quality control infrastructure, and rapid,
reliable analysis for research trials. Standard RECIST measurements are performed
by trained radiology technologists then reviewed by Mayo Clinic radiologists who have
additional training in clinical trial measurement protocols. The measurements are
made with Mint Lesion V3.0 (Mint Medical, Heidelberg Germany), a commercial,
FDA-cleared software designed for this purpose. These provide a great environment
to validate this application. To integrate this application into the core lab workflow,
more models need to be implemented. First, we need to establish the connection to
image database in the radiology picture archiving and communication system (PACS).
Then after the measurement, the volume and/or the segmentation (saved as a binary
mask) should be send back to PACS. In addition, a reporting model to present the
measurement numerically and graphically is helpful to clinicians and patients.
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6.1.4.2 Clinical Research Studies
We conducted one clinical research study on ICH stroke with 76 patients. It
is a comprehensive and time consuming process, but more retrospective validation
studies should be conducted to evaluate the bias, precision, and acquisition time of this
application and to advance quantitative imaging technology. New studies should follow
the test-retest framework described in Chapter 5. For instance, a good validate study
could be applied to glioblastoma (GBM) tumor volume measurement. Volumetric and
parameters of GBM tumor have been used to predict the prognosis and to determine
treatment failure (Iliadis et al., 2012; Grabowski et al., 2014). Contrast-enhancing
residual tumor volume (CERTV) alone significantly predicts survival after GBM
resection, reflecting the pathobiology of GBM. However, this quantitative information
is rarely recorded in clinical practice. Additional validation study is needed to prove
the concept of adopting this application to such case
6.2 Potential Impact on Biomedical Research
In addition to volume information, this application obtains the entire morphological
information of the anatomical structures, such as the shape and location. These are
valuable to other biomedical image based research.
6.2.1 Extract GBM Brain Tumor
The Mathematical Neuro-Oncology (MNO) lab at Mayo Clinic focuses on cancer
research to build mathematical models to predict cancer patient’s prognosis and to
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optimize treatment. One system in their lab monitors the longitudinal patient’s
tumor size from multiple MRI data along with the treatments. The goal is to provide
personalized precision treatment choices to improve the lives of patients with brain
cancer (Neal et al., 2013b,a). As shown from the figure below, a patient had about
50 measurements during 3 years of cancer treatment. MNO uses a measurement
team to delineate tumor boundaries from T1, T2, and FLAIR MRI data. Currently
the operators of the measurement team manually trace tumors. This application
can significantly increase their productivity. More data could lead to more research
discoveries and better outcome of cancer patients.
Figure 17. Brain tumor patient graph with tumor radius and treatments.
We conducted a preliminary study to evaluate this application’s performance
on segmenting brain tumors. This application achieved comparable results as the
state-of-the-art methods when segmenting whole tumor using BRATS 2013 MRI data,
and achieved acceptable results comparing to human labeled references using MNO’s
own MRI data.
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6.2.2 Personalized Neurosurgery
Another research area is neurosurgery, which requires the accurate structure of the
target region. This application had been frequently used by a team of neurosurgery
researchers at Mayo Clinic Arizona to extract vessels and aneurysms from brain CT
angiography. First, the surgeon would prefer a 3D visualization of the aneurysm
and surrounding vessels to plan the surgery. Then the binary segmentations were
converted to 3D meshes. With the current development of 3D printing, the 3D meshes
were used to 3D print the vessels and aneurysm. 3D printing technology brings
anatomic structures showing on the digital screen to the palms of the surgeons. It
allows the surgeons to examine and to simulate and practice prior to the real surgery.
For aneurysm, they can test multiple treatment plans and identify the best way to
treat the specific patient. This can shorten the real surgery time and improve the
healthcare quality. In addition to surgery planning, these 3D printed anatomical
structures provide great education to both patients and medical students/residents.
For a preliminary study with one CT angiography from a patient, we compared
the vessel and aneurysm segmentation using this method to a human labeled reference
and found the largest difference between the two surfaces was less than 1 mm, which
is subvoxel. But, the human labeling process took hours to only obtain a small region
while this application could extract much more vessels within minutes.
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Figure 18. A photo of the 3D printed vessel and aneurysm using silicon.
6.2.3 Future Work
6.2.3.1 Automatic Seed Generating
One limitation of this application is that the users need to place foreground and
background seed points. After the validation study showing this application is able to
obtain accurate and precise results, auto seed generating becomes the next step in order
to eliminate the human inputs and fully automate the entire process. This can reduce
the variability associated with different operators (researchers or clinicians). One
potential way to achieve auto seeding is to identify statistical image feature model and
using the voxels with high probabilities belonging to the background and foreground
as background and foreground seed points, respectively. In addition, registering atlas
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Figure 19. A 3D visualization of the segmentation of neurovascular and anuerysm
from CT angiography using this application.
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could be used to create background seed points if we are trying to segment abnormality
from a healthy anatomy, such as registering brain atlas to a patient with brain tumor
to find healthy tissues and sampling these voxels as background seed points to extract
brain tumor. Then the user only needs to place foreground seed points to mark the
tumor region.
6.2.3.2 Using Different Framework
We showed how to segment MS lesions in previous chapter (4). We proposed
a new iterative framework, which integrates the stand alone application,to obtain
a complicated task. We segmented MS lesions with multiple steps by segmenting
different regions using different combination of seeds from multiple contrast MRI
images. It is very difficult to achieve that with one pass of segmentation. This
study shows the potential of this application being used in different ways to solve
complex problems and encourages future researches to extend this application to other
frameworks.
6.2.3.3 Embedding to Open Source Softwares
Translation to an open source research softwares, like 3D slicer (Fedorov et al.,
2012). First is separating the core algorithms from this application. The core includes
two parts: the speed computation and GPU level set method. The speed function
requires 1) one or more (coregistered) medical images and 2) user labeled seed points
as inputs. All of these inputs could be handled by Slicer. The speed function generates
a speed volume as output which could be stored as an ITK float image. On the other
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hand, the GPU level set part takes 1) a speed volume, 2) foreground labels (where the
growth starts), and 3) a tuning parameter (weight of surface smoothness) as inputs.
The tuning parameter could be set by users with a Qt slider in Slicer. The GPU level
set generates a binary mask as output, which could be stored as an ITK UInt8 image.
The second step is linking it to Slicer. Slicer provides users the abilities of loading
and viewing medical images, labeling seeds, tuning parameter, and saving feature
volume and binary mask with its IO, user interaction, and visualization modules.
After the integration, we hope the extension could achieve the following three
scenarios:
1. Using speed function only: generating speed volume based on user labeled seeds
and images as inputs. The output ITK image could be used for data visualization
or colormap, in addition to guide GPU level set growth.
2. Using GPU level set only: generating a binary mask with a user specified
parameter, foreground seeds (could load from a file), and speed volume (could
be loaded from a file) as inputs. This is for general image segmentation task.
And users could load their own precomputed speed volume.
3. Using speed function guided GPU level set: generating a binary mask with
images, user labeled seeds, and user tuned parameter as inputs. This is the
process I demoed during my presentation. Note that all the scenarios could be
executed in console by passing parameter and file names of images, seed files,
and speed file as arguments.
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Chapter 7
CONCLUSION
Precise and unbiased measurement of tumor/lesion volume is important for cancer
staging and therapeutic assessment. The current methods used in clinical practice
emphasize on efficiency, but suffer from low bias and precision. In the other hand,
computational algorithms focus on improving the accuracy, but are often time con-
suming and cumbersome to use. In addition, most of them lack validation studies to
evaluate their practical impact to healthcare. All of these hinder the translation of
advanced methods from benchside to bedside, thus not able to increase the healthcare
outcome.
In this dissertation, I propose a user interactive image application to rapidly extract
accurate quantitative information of abnormalities (tumor/lesion) from multi-spectral
medical images, such as measuring brain tumor volume from MRI. This user interactive
image segmentation application has a simple and intuitive graphical user interface. It
requires the users to place foreground and background seed points, where foreground
seeds label the desired region and background seeds label the undesired region. Theses
seeds are used to generate prior image features to guide the surface propagation.
Then the users can simply start the method to extract the targeted region. Only one
parameter needs to be specified in order to adjust the surface smoothness. It could be
empirically initialized based on image noise level to obtain optimal results and can be
tuned by the users in real time. In addition, a comprehensive workflow is presented
to validate image quantitative methods for clinical studies.
This application has been evaluated and validated in multiple cases, including
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segmenting healthy brain white matter from MRI and brain lesions from CT or MRI.
A retrospective validation study is conducted on measuring intracerebral hemorrhage
volume from CT scan following this workflow. Such validations have not been done
for most of the advanced computational methods.
These evaluations show that this application is capable to achieve low bias and high
precision on volume measurement of ROIs. In particular, the clinical validation study
with a large dataset demonstrates that this application appears to have measurement
attributes superior to the current practice method in terms of accuracy and reliability
without a significant delay in acquisition time. In other words, it could be useful to the
clinical trials and clinical practice, especially when intervention and prognostication
rely upon accurate baseline lesion volume or upon detecting change in serial lesion
volumetric measurements. More clinical proof-of-concept studies should be conducted
in order to validate the performance and to advance the role of quantitative image
metrics in patient care.
Additionally, other biomedical researches, which require extracting information
from medical images, could greatly benefit from this application also. As a general
image segmentation tool, this application provides structural and morphological
information in addition to the quantitative volumetric information. This could be
used in researches such as predicting tumor growth, surgery planning. In order to
reach a broader research community, this application could be embedded into popular
open-source medical image platforms.
82
REFERENCES
Anandh, K. R., C. M. Sujatha and S. Ramakrishnan, “Atrophy analysis of corpus
callosum in Alzheimer brain MR images using anisotropic diffusion filtering and
level sets”, in “2014 36th Annual International Conference of the IEEE Engineering
in Medicine and Biology Society, EMBC 2014”, pp. 1945–1948 (2014).
Berger, A., “How does it work?: Magnetic resonance imaging”, BMJ: British Medical
Journal 324, 7328, 35 (2002).
Boykov, Y. and M.-P. Jolly, “Interactive graph cuts for optimal boundary amp; region
segmentation of objects in n-d images”, in “Computer Vision, 2001. ICCV 2001.
Proceedings. Eighth IEEE International Conference on”, vol. 1, pp. 105 –112 vol.1
(2001).
Boykov, Y. and V. Kolmogorov, “An experimental comparison of min-cut/max- flow
algorithms for energy minimization in vision”, Pattern Analysis and Machine Intelli-
gence, IEEE Transactions on 26, 9, 1124 –1137 (2004).
Brinkley, J. F. and C. Rosse, “Imaging and the Human Brain Project: a review.”,
Methods of information in medicine 41, 245–260 (2002).
Broderick, J., T. Brott, J. Duldner, T. Tomsick and G. Huster, “Volume of Intracerebral
Hemorrhage A Powerful and Easy-to-Use Predictor of 30-Day Mortality”, Stroke.
24, 7, 987–93 (1993).
Brosch, T., Y. Yoo, L. Y. Tang, D. K. Li, A. Traboulsee and R. Tam, “Deep convolu-
tional encoder networks for multiple sclerosis lesion segmentation”, in “MICCAI”,
pp. 3–11 (Springer, 2015).
Buzug, T. M., Computed tomography: from photon statistics to modern cone-beam
CT (Springer Science & Business Media, 2008).
Caselles, V., F. Catt, T. Coll and F. Dibos, “A geometric model for active contours in
image processing”, Numerische Mathematik 66, 1–31, URL http://dx.doi.org/10.
1007/BF01385685 (1993).
Cates, J. E., A. E. Lefohn and R. T. Whitaker, “GIST: an interactive, GPU-based
level set segmentation tool for 3D medical images.”, Medical Image Analysis 8,
217–231 (2004).
Cocosco, C. A., V. Kollokian, R. K.-S. Kwan, G. B. Pike and A. C. Evans, “Brainweb:
Online interface to a 3d mri simulated brain database”, NeuroImage 5, 425 (1997).
83
Collins, D. L., A. P. Zijdenbos, V. Kollokian, J. G. Sled, N. J. Kabani, C. J. Holmes
and A. C. Evans, “Design and construction of a realistic digital brain phantom.”,
IEEE transactions on medical imaging 17, 3, 463–8, URL http://www.ncbi.nlm.
nih.gov/pubmed/9735909 (1998).
Colliot, O., T. Mansi, N. Bernasconi, V. Naessens, D. Klironomos and A. Bernasconi,
“Segmentation of focal cortical dysplasia lesions on MRI using level set evolution”,
NeuroImage 32, 4, 1621–1630 (2006).
Cootes, T. F., G. J. Edwards and C. J. Taylor, “Active appearance models”, in “IEEE
Transactions on Pattern Analysis and Machine Intelligence”, pp. 484–498 (Springer,
1998).
Cootes, T. F., C. J. Taylor, D. H. Cooper and J. Graham, “Active shape models
their training and application”, Comput. Vis. Image Underst. 61, 1, 38–59, URL
http://dx.doi.org/10.1006/cviu.1995.1004 (1995).
Dang, M., J. Modi, M. Roberts, C. Chan and J. R. Mitchell, “Validation study of a
fast, accurate, and precise brain tumor volume measurement.”, Computer methods
and programs in biomedicine 111, 2, 480–7 (2013).
Davis, S. M., J. Broderick, M. Hennerici, N. C. Brun, M. N. Diringer, S. A. Mayer,
K. Begtrup and T. Steiner, “Hematoma growth is a determinant of mortality and
poor outcome after intracerebral hemorrhage”, Neurology 66, 8, 1175–1181 (2006).
Demirkaya, O., M. H. Asyali and P. K. Sahoo, Image Processing with Matlab: Appli-
cations in Medicine and Biology (CRC Press Taylor & Francis Group Boca Raton,
2009).
Divani, A. A., S. Majidi, X. Luo, F. G. Souslian, J. Zhang, A. Abosch and R. P.
Tummala, “The ABCs of accurate volumetric measurement of cerebral hematoma”,
Stroke 42, 6, 1569–1574 (2011).
Dowlatshahi, D., A. M. Demchuk, M. L. Flaherty, M. Ali, P. L. Lyden and E. E.
Smith, “Defining hematoma expansion in intracerebral hemorrhage: Relationship
with patient outcomes”, Neurology 76, 14, 1238–1244 (2011).
Duda, R. O., P. E. Hart and D. G. Stork, Pattern Classification (2Nd Edition)
(Wiley-Interscience, 2000).
Eklund, A., P. Dufort, D. Forsberg and S. M. Laconte, “Medical image processing
on the GPU - Past, present and future.”, Medical image analysis 17, 8, 1073–1094,
URL http://www.ncbi.nlm.nih.gov/pubmed/23906631 (2013).
84
Eliasziw, M., S. L. Young, M. G. Woodbury and K. Fryday-Field, “Statistical method-
ology for the concurrent assessment of interrater and intrarater reliability: using
goniometric measurements as an example.”, Physical therapy 74, 777–788 (1994).
Falcao, A. X., J. K. Udupa, S. Samarasekera, S. Sharma, B. E. Hirsch and
R. de A. Lotufo, “User-steered image segmentation paradigms: Live wire and
live lane”, Graphical Models and Image Processing 60, 4, 233 – 260, URL
http://www.sciencedirect.com/science/article/pii/S1077316998904750 (1998).
Fedorov, A., R. Beichel, J. Kalpathy-Cramer, J. Finet, J. C. Fillion-Robin, S. Pujol,
C. Bauer, D. Jennings, F. Fennessy, M. Sonka, J. Buatti, S. Aylward, J. V. Miller,
S. Pieper and R. Kikinis, “3D Slicer as an image computing platform for the
Quantitative Imaging Network”, Magnetic Resonance Imaging 30, 9, 1323–1341
(2012).
Feigin, V. L., C. M. Lawes, D. A. Bennett, C. S. Anderson, C. Sarti, D. Rastenyte,
Z. Cepaitis, J. Tuomilehto, C. Murray, A. Lopez, WHO, WHO, M. Foulkes, P. Wolf,
T. Price, J. Mohr, D. Hier, J. Caro, K. Huybrechts, I. Duchesne, WHO, R. Bonita,
A. Stewart, R. Beaglehole, P. Thorvaldsen, K. Kuulasmaa, A. Rajakangas, D. Ras-
tenyte, C. Sarti, L. Wilhelmsen, R. Bonita, R. Bonita, R. Beaglehole, K. Asplund,
C. Sudlow, C. Warlow, C. Warlow, K. Khaw, J. Posner, K. Gorman, A. Woldow,
J. Kurtzke, J. Mas, M. Zuber, A. Viriyavejakul, S. Hatano, C. Sudlow, C. Warlow,
O. Ahmad, C. Boschi-Pinto, C. Murray, R. Lozano, M. Inoue, A. s. o. r. a. n. W. world
Standard, A. Thrift, H. Dewey, R. Macdonell, J. McNeil, G. Donnan, K. Jamrozik,
R. Broadhurst, N. Lai, G. Hankey, P. Burvill, C. Anderson, H. Jorgensen, A. Plesner,
P. Hubbe, K. Larsen, J. Stewart, R. Dundas, R. Howard, A. Rudd, C. Wolfe, H. Num-
minen, M. Kotila, O. Waltimo, K. Aho, M. Kaste, D. Smadja, P. Cabre, F. May,
et Al., Y. Morikawa, H. Nakagawa, Y. Naruse, et Al., P. Kolominsky-Rabas, M. We-
ber, O. Gefeller, B. Neundoerfer, P. Heuschmann, P. Kolominsky-Rabas, C. Sarti,
P. Heuschmann, C. Graf, S. Siemonsen, B. Neundoerfer, et Al., K. Vemmos, M. Bots,
P. Tsibouris, et Al., G. Lauria, M. Gentile, G. Fassetta, et Al., A. Carolei, C. Marini,
M. D. Napoli, et Al., R. Bonita, J. Broad, R. Beaglehole, H. Ellekjaer, J. Holmen,
B. Indredavik, A. Terent, V. Feigin, D. Wiebers, Y. Nikitin, W. O’Fallon, J. Whis-
nant, L. Mihalka, V. Smolanka, B. Bulecza, S. Mulesa, D. Bereczki, R. Bonita,
N. Solomon, J. Broad, M. Bots, S. Looman, P. Koudstaal, A. Hofman, A. Hoes,
D. Grobbee, A. Nicoletti, V. Sofia, S. Giuffrida, et Al., M. Mittelmark, B. Psaty,
P. Rautaharju, et Al., J. Geddes, J. Fear, A. Tennant, A. Pickering, M. Hillman,
M. Chamberlain, P. O’Mahony, R. Thomson, R. Dobson, H. Rodgers, O. James,
S. Lindeberg, B. Lundh, Z. Huang, T. Chiang, T. Lee, M. Prencipe, C. Ferretti,
A. Casini, M. Santini, F. Giubilei, F. Culasso, F. Bermejo, S. Vega, J. Morales,
et Al., P. Thorvaldsen, M. Davidsen, H. Bronnum-Hansen, M. Schroll, R. Brown,
J. Whisnant, J. Sicks, W. O’Fallon, D. Wiebers, V. Feigin, D. Wiebers, J. Whisnant,
W. O’Fallon, B. Stegmayr, K. Asplund, P. Wester, A. Czlonkowska, D. Ryglewicz,
85
T. Weissbein, M. Baranska-Gieruszczak, D. Hier, M. Rodrigues, M. Noronha,
M. Vieira-Dias, et Al., R. Walker, D. McLarty, G. Masuki, et Al., T. Banerjee,
C. Mukherjee, A. Sarkhel, S. Das, K. Sanyal, P. Thorvaldsen, K. Asplund, K. Kuulas-
maa, A.-M. Rajakangas, M. Schroll, T. Ingall, K. Asplund, M. Mahonen, R. Bonita,
G. Petty, R. Brown, J. Whisnant, J. Sicks, W. O’Fallon, D. Wiebers, K. Aho, A. Re-
unanen, A. Aromaa, P. Knekt, J. Maatela, N. Bharucha, E. Bharucha, A. Bharucha,
A. Bhise, B. Schoenberg, H. Hu, F. Chu, B. Chiang, et Al., S. Li, B. Schoen-
berg, C. Wang, X. Cheng, C. Bolis, K. Wang, C. Paschalis, P. Polychronopoulos,
N. Makris, X. Kondakis, T. Papapetropoulos, S. Razdan, R. Koul, A. Motta, S. Kaul,
S. Sorensen, G. Boysen, G. Jensen, P. Schnohr, K. Urakami, M. Igo, K. Takahashi,
T. Wyller, E. Bautz-Holter, J. Holmen, A. Terént, F. Linn, G. Rinkel, A. Algra,
J. van Gijn, J. Tuomilehto, C. Sarti, E. Narva, et Al., J. Okwumabua, B. Mar-
tin, J. Clayton-Davis, C. Pearson, R. Sacco, B. Boden-Albala, R. Gan, et Al.,
R. Bonita, J. Broad, R. Beaglehole, T. Truelsen, R. Bonita, K. Jamrozik, R. Bonita,
R. Beaglehole, K. Tilling, J. Sterne, C. Wolfe, K. Asplund, R. Bonita, K. Kuu-
lasmaa, et Al., D. Schottenfeld, M. Eaton, S. Sommers, D. Alonso, C. Wilkinson,
H. Cameron, E. McGoogan, M. Britton, J. Bamford, P. Sandercock, M. Dennis,
et Al., M. Alter, E. Sobel, R. McCoy, et Al., C. Sarti, J. Tuomilehto, J. Sivenius,
et Al., B. Stegmayr, K. Asplund, R. Malmgren, C. Warlow, J. Bamford, P. Sander-
cock, R. Bonita, J. Broad, N. Anderson, R. Beaglehole, T. Thom, K. Jamrozik,
J. Reitsma, M. Limburg, J. Kleijnen, G. Bonsel, J. Tijssen, R. Gillum, C. Sempos,
O. Ahmed, T. Orchard, R. Sharma, H. Mitchell, E. Talbot, J. Fang, M. Alderman,
J. Tu, Y. Hong, M. Bots, X. Pan, A. Hofman, D. Grobbee, H. Chen, G. Howard,
T. Craven, L. Sanders, G. Evans, P. Heidenreich, M. McClellan, M. Rosen, L. Alfreds-
son, N. Hammar, T. Kahan, C. Spetz, A. Ysberg, I. Bata, R. Gregor, B. Eastwood,
H. Wolf, F. Spencer, T. Meyer, R. Goldberg, et Al., M. Kirchhoff, M. David-
sen, H. Bronnum-Hansen, et Al., R. Goldberg, J. Yarzebski, D. Lessard, J. Gore,
J. Volmink, J. Newton, N. Hicks, et Al., W. Rosamond, L. Chambless, A. Folsom,
et Al., J. Brophy, P. Immonen-Raiha, M. Arstila, J. Tuomilehto, et Al. and R. Bea-
glehole, “Stroke epidemiology: a review of population-based studies of incidence,
prevalence, and case-fatality in the late 20th century”, The Lancet Neurology 2, 1,
43–53 (2000).
Fitzpatrick, J. M. and M. Sonka, "Handbook of Medical Imaging, Volume 2. Medical
Image Processing and Analysis (SPIE Press Monograph Vol. PM80)" (SPIE–The
International Society for Optical Engineering, 2000), 1 edn.
Flaherty, M. L., M. Haverbusch, P. Sekar, B. Kissela, D. Kleindorfer, C. J. Moomaw,
L. Sauerbeck, A. Schneider, J. P. Broderick and D. Woo, “Long-term mortality after
intracerebral hemorrhage”, Neurology 66, 8, 1182–1186 (2006).
Freeman, W. D., K. M. Barrett, J. M. Bestic, J. F. Meschia, D. F. Broderick and
T. G. Brott, “Computer-assisted volumetric analysis compared with ABC/2 method
86
for assessing warfarin-related intracranial hemorrhage volumes”, Neurocritical Care
9, 3, 307–312 (2008).
Freire, P. G. L. and R. J. Ferrari, “Automatic iterative segmentation of multiple
sclerosis lesions using Student’s t mixture models and probabilistic anatomical
atlases in FLAIR images”, Computers in Biology and Medicine 73, 10–23 (2016).
García-Lorenzo, D., S. Francis, S. Narayanan, D. L. Arnold and D. L. Collins, “Review
of automatic segmentation methods of multiple sclerosis white matter lesions on
conventional magnetic resonance imaging”, Medical Image Analysis 17, 1, 1–18
(2013).
García-Lorenzo, D., J. Lecoeur, D. L. Arnold, D. L. Collins and C. Barillot, “Multiple
sclerosis lesion segmentation using an automatic multimodal graph cuts.”, MICCAI
12, Pt 2, 584–91 (2009).
Ge, Y., R. I. Grossman, J. S. Babb, M. L. Rabin, L. J. Mannon and D. L. Kolson,
“Age-Related Total Gray Matter and White Matter Changes in Normal Adult
Brain. Part I: Volumetric MR Imaging Analysis”, AJNR Am. J. Neuroradiol. 23, 8,
1327–1333, URL http://www.ajnr.org/content/23/8/1327.full (2002).
Geremia, E., O. Clatz, B. H. Menze, E. Konukoglu, A. Criminisi and N. Ayache,
“Spatial decision forests for MS lesion segmentation in multi-channel magnetic
resonance images.”, NeuroImage 57, 2, 378–90 (2011).
Giedd, J. N., J. Blumenthal, N. O. Jeffries, F. X. Castellanos, H. Liu, A. Zijdenbos,
T. Paus, A. C. Evans and J. L. Rapoport, “Brain development during childhood and
adolescence: a longitudinal MRI study.”, Nature neuroscience 2, 10, 861–3, URL
http://dx.doi.org/10.1038/13158 (1999).
Goldstein, L. B., “CLINICIAN ’ S CORNER Is This Patient Having a Stroke ?
EXAMINATION OF PATIENTS WITH SUSPECTED STROKE”, Stroke 293,
19, 2391–2402, URL http://stroke.ahajournals.org/cgi/content/abstract/37/9/2378
(2005).
Grabowski, M. M., P. F. Recinos, A. S. Nowacki, J. L. Schroeder, L. Angelov, G. H.
Barnett and M. a. Vogelbaum, “Residual tumor volume versus extent of resection:
predictors of survival after surgery for glioblastoma”, Journal of Neurosurgery v,
November, 1–9 (2014).
Grady, L., “Random walks for image segmentation”, IEEE Trans. on Pattern Analysis
and Machine Intelligence 28, 11, 1768–1783 (2006).
Hemphill, J. C., D. C. Bonovich, L. Besmertis, G. T. Manley and S. C. John-
ston, “The ICH Score A Simple, Reliable Grading Scale for Intracerebral
87
Hemorrhage”, Stroke 32, 4, 891–897, URL http://stroke.ahajournals.org/
content/32/4/891$\delimiter"026E30F$nhttp://stroke.ahajournals.org.ezp-
prod1.hul.harvard.edu/content/32/4/891.abstract$\delimiter"026E30F$nhttp:
//stroke.ahajournals.org/content/32/4/891.full.pdf (2001).
Hirono, N., H. Kitagaki, H. Kazui, M. Hashimoto and E. Mori, “Impact of White
Matter Changes on Clinical Manifestation of Alzheimer’s Disease : A Quantitative
Study”, Stroke 31, 9, 2182–2188, URL http://stroke.ahajournals.org/content/31/9/
2182.long (2000).
Iliadis, G., V. Kotoula, A. Chatzisotiriou, D. Televantou, A. G. Eleftheraki, S. Lambaki,
D. Misailidou, P. Selviaridis and G. Fountzilas, “Volumetric and MGMT parameters
in glioblastoma patients: Survival analysis”, BMC Cancer 12, 1, 3 (2012).
Immerkæ r, J., “Fast Noise Variance Estimation”, Computer Vision and Image Under-
standing 64, 300–302 (1996).
Ivanovska, T., R. Laqua, L. Wang, A. Schenk, J. H. Yoon, K. Hegenscheid, H. Völzke
and V. Liebscher, “An efficient level set method for simultaneous intensity inhomo-
geneity correction and segmentation of MR images”, Computerized Medical Imaging
and Graphics 48, 9–20 (2016).
Kass, M., A. Witkin and D. Terzopoulos, “Snakes: Active contour models”, INTER-
NATIONAL JOURNAL OF COMPUTER VISION 1, 4, 321–331 (1988).
Kessler, L. G., H. X. Barnhart, A. J. Buckler, K. R. Choudhury, M. V. Kondratovich,
A. Toledano, A. R. Guimaraes, R. Filice, Z. Zhang and D. C. Sullivan, “The emerging
science of quantitative imaging biomarkers terminology and definitions for scientific
studies and regulatory submissions.”, Statistical Methods in Medical Research 24,
1, 9–26, URL http://www.ncbi.nlm.nih.gov/pubmed/24919826 (2015).
Kosior, J. C., S. Idris, D. Dowlatshahi, M. Alzawahmah, M. Eesa, P. Sharma, S. Tym-
chuk, M. D. Hill, R. I. Aviv, R. Frayne and A. M. Demchuk, “Quantomo: validation
of a computer-assisted methodology for the volumetric analysis of intracerebral
haemorrhage”, International Journal of Stroke 6, 4, 302–305 (2011).
Kothari, R. U., T. Brott, J. P. Broderick, W. G. Barsan, L. R. Sauerbeck, M. Zuccarello
and J. Khoury, “The ABCs of measuring intracerebral hemorrhage volumes”, Stroke
27, 8, 1304–1305, URL papers://490fc991-209f-415a-8b63-00fbb1df9aa5/Paper/
p5097 (1996).
Lefohn, A. E., J. E. Cates and R. T. Whitaker, “Interactive , GPU-Based Level Sets
for 3D Segmentation”, LNCS 2878 Proc MICCAI pp. 564–572 (2003a).
88
Lefohn, A. E., J. M. Kniss, C. D. Hansen and R. T. Whitaker, “Interactive deformation
and visualization of level set surfaces using graphics hardware”, IEEE Transactions
on Ultrasonics Ferroelectrics and Frequency Control 10, 75–82 (2003b).
Lefohn, A. E., J. M. Kniss, C. D. Hansen and R. T. Whitaker, “A streaming narrow-
band algorithm: interactive computation and visualization of level sets”, IEEE
Transactions on Visualization and Computer Graphics 10, 422–33 (2004).
Malladi, R., J. Sethian and B. Vemuri, “Shape modeling with front propagation: a
level set approach”, Pattern Analysis and Machine Intelligence, IEEE Transactions
on 17, 2, 158 –175 (1995).
McInerney, T. and D. Terzopoulos, “Deformable models in medical image analysis: A
survey”, Medical Image Analysis 1, 91–108 (1996).
Menze, B., M. Reyes and K. Van Leemput, “The Multimodal Brain TumorImage
Segmentation Benchmark (BRATS).”, IEEE transactions on medical imaging PP,
99, 1 (2014).
Mettler Jr, F. A. and M. J. Guiberteau, Essentials of nuclear medicine imaging
(Elsevier Health Sciences, 2011).
Mitchell, J. R., S. J. Karlik, D. H. Lee, M. Eliasziw, G. P. Rice and A. Fenster, “The
variability of manual and computer assisted quantification of multiple sclerosis lesion
volumes.”, Medical physics 23, 85–97 (1996).
Mitchell, J. R., S. J. Karlik, D. H. Lee and A. Fenster, “Computer-assisted identification
and quantification of multiple sclerosis lesions in MR imaging volumes in the brain.”,
J Magn Reson Imaging 4, 2, 197–208 (1994).
Morgenstern, L. B., J. C. Hemphill, C. Anderson, K. Becker, J. P. Broderick, E. S. Con-
nolly, S. M. Greenberg, J. N. Huang, R. L. MacDonald, S. R. Messé, P. H. Mitchell,
M. Selim and R. J. Tamargo, “Guidelines for the management of spontaneous in-
tracerebral hemorrhage: a guideline for healthcare professionals from the American
Heart Association/American Stroke Association.”, Stroke; a journal of cerebral
circulation 41, 9, 2108–29, URL http://www.ncbi.nlm.nih.gov/pubmed/20651276
(2010).
Mortensen, E. N. and W. A. Barrett, “Interactive segmentation with intelligent
scissors”, Graphical Models and Image Processing 60, 5, 349 – 384, URL http:
//www.sciencedirect.com/science/article/pii/S1077316998904804 (1998).
Neal, M. L., A. D. Trister, S. Ahn, A. Baldock, C. A. Bridge, L. Guyman, J. Lange,
R. Sodt, T. Cloke, A. Lai, T. F. Cloughesy, M. M. Mrugala, J. K. Rockhill, R. C.
Rockne and K. R. Swanson, “Response classification based on a minimal model of
89
glioblastoma growth is prognostic for clinical outcomes and distinguishes progression
from pseudoprogression”, Cancer Research 73, 10, 2976–2986 (2013a).
Neal, M. L., A. D. Trister, T. Cloke, R. Sodt, S. Ahn, A. L. Baldock, C. A. Bridge,
A. Lai, T. F. Cloughesy, M. M. Mrugala, J. K. Rockhill, R. C. Rockne and K. R.
Swanson, “Discriminating Survival Outcomes in Patients with Glioblastoma Using
a Simulation-Based, Patient-Specific Response Metric”, PLoS ONE 8, 1 (2013b).
NVIDIA, “NVIDIA CUDA Programming Guide”, (2012).
Osher, S. and R. P. Fedkiw, “Level set methods: An overview and some recent results”,
Journal of Computational Physics 169, 2, 463 – 502 (2001).
Osher, S. and J. A. Sethian, “Fronts propagating with curvature-dependent speed:
Algorithms based on hamilton-jacobi formulations”, Journal of Computational
Physics 79, 1, 12 – 49, URL http://www.sciencedirect.com/science/article/pii/
0021999188900022 (1988a).
Osher, S. and J. A. Sethian, “Fronts propagating with curvature-dependent speed:
Algorithms based on Hamilton-Jacobi formulations”, Journal of Computational
Physics 79, 1, 12–49 (1988b).
Roberts, M., J. Packer, M. C. Sousa and J. R. Mitchell, “A work-efficient GPU
algorithm for level set segmentation”, in “High Performance Graphics (HPG ’10)”,
pp. 123–132 (2010).
Roberts, M., M. Sousa and J. Mitchell, “Level set segmentation of volume data”, URL
https://www.google.com/patents/US9082191, uS Patent 9,082,191 (2015).
Rosset, A., L. Spadola and O. Ratib, “OsiriX: An open-source software for navigating in
multidimensional DICOM images”, Journal of Digital Imaging 17, 205–216 (2004).
Rother, C., V. Kolmogorov and A. Blake, “"grabcut": interactive foreground extraction
using iterated graph cuts”, in “ACM SIGGRAPH 2004 Papers”, SIGGRAPH ’04,
pp. 309–314 (ACM, New York, NY, USA, 2004), URL http://doi.acm.org/10.1145/
1186562.1015720.
Saba, L., H. Gao, E. Raz, S. V. Sree, L. Mannelli, N. Tallapally, F. Molinari, P. P.
Bassareo, U. R. Acharya, H. Poppert and J. S. Suri, “Semiautomated analysis of
carotid artery wall thickness in MRI”, Journal of Magnetic Resonance Imaging 39,
6, 1457–1467 (2014).
Sacco, S., C. Marini, D. Toni, L. Olivieri and A. Carolei, “Incidence and 10-Year
Survival of Intracerebral Hemorrhage in a Population-Based Registry”, Stroke 40, 2
(2009).
90
Saha, P. and J. Udupa, “Iterative relative fuzzy connectedness and object definition:
theory, algorithms, and applications in image segmentation”, in “Mathematical
Methods in Biomedical Image Analysis, 2000. Proceedings. IEEE Workshop on”,
pp. 28 –35 (2000).
Sanfilipo, M. P., R. H. B. Benedict, B. Weinstock-Guttman and R. Bakshi, “Gray and
white matter brain atrophy and neuropsychological impairment in multiple sclerosis.”,
Neurology 66, 5, 685–92, URL http://www.neurology.org/content/66/5/685 (2006).
Sethian, J. A., Level set methods and fast marching methods: evolving interfaces in
computational geometry, fluid mechanics, computer vision, and materials science,
vol. 3 (Cambridge university press, 1999).
Shortliffe, E. H. and J. J. Cimino, Biomedical informatics (Springer, 2006).
Styner, M., J. Lee, B. Chin and M. Chin, “3D segmentation in the clinic: A grand
challenge II: MS lesion segmentation”, MIDAS pp. 1–6 (2008).
T, B., J. Broderick, R. Kothari, W. Barsan, T. Tomsick, L. Sauerbeck, J. Spilker,
J. Duldner and J. Khoury, “Early hemorrhage growth in patients with intracerebral
hemorrhage.”, Stroke. 28, 1, 1–5 (1997).
Tsang, O., A. Gholipour, N. Kehtarnavaz, K. Gopinath, R. Briggs and I. Panahi,
“Comparison of tissue segmentation algorithms in neuroimage analysis software
tools.”, Conference proceedings : Annual International Conference of the IEEE
Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and
Biology Society. Conference 2008, 3924–3928 (2008).
Udupa, J. K. and S. Samarasekera, “Fuzzy connectedness and object definition: Theory,
algorithms, and applications in image segmentation”, CVGIP: Graphical Model and
Image Processing 58, 3, 246–261 (1996).
Wang, C.-W., C.-J. Juan, Y.-J. Liu, H.-H. Hsu, H.-S. Liu, C.-Y. Chen, C.-J. Hsueh,
C.-P. Lo, H.-W. Kao and G.-S. Huang, “Volume-dependent overestimation of spon-
taneous intracerebral hematoma volume by the ABC/2 formula.”, Acta radiologica
(Stockholm, Sweden : 1987) 50, 3, 306–11, URL http://www.ncbi.nlm.nih.gov/
pubmed/19173095 (2009).
Webb, A. J. S., N. L. Ullman, T. C. Morgan, J. Muschelli, J. Kornbluth, I. A. Awad,
S. Mayo, M. Rosenblum, W. Ziai, M. Zuccarrello, F. Aldrich, S. John, S. Harnof,
G. Lopez, W. C. Broaddus, C. Wijman, P. Vespa, R. Bullock, S. J. Haines, S. Cruz-
Flores, S. Tuhrim, M. D. Hill, R. Narayan and D. F. Hanley, “Accuracy of the
ABC/2 Score for Intracerebral Hemorrhage: Systematic Review and Analysis of
MISTIE, CLEAR-IVH, and CLEAR III”, Stroke 46, 9, 2470–2476 (2015).
91
Whitaker, R. T., “Volumetric Deformable Models: Active Blobs”, in “Visualization In
Biomedical Computing 1994”, pp. 122–134 (1994).
Woo, D., J. P. Broderick, , N. I. o. N. D. Stroke, C. Sudlow, C. Warlow, C. Sudlow,
C. Warlow, J. Broderick, T. Brott, T. Tomsick, et Al., J. Mohr, L. Caplan, J. Mel-
ski, et Al., J. Bamford, P. Sandercock, M. Dennis, et Al., J. Broderick, T. Brott,
T. Tomsick, et Al., J. Broderick, S. Phillips, J. Whisnant, et Al., R. Fogelholm,
M. Nuutila, A.-L. Vuorela, M. Giroud, E. Creisson, H. Fayolle, et Al., J. Broderick,
T. Brott, J. Duldner, et Al., P. Daverat, J. Castel, J. Dartigues, et Al., R. Portenoy,
R. Lipton, A. Berger, et Al., S. Tuhrim, J. Dambrosia, T. Price, et Al., S. Tuhrim,
J. Dambrosia, T. Price, et Al., W. Young, K. Lee, M. Pessin, et Al., T. Brott,
J. Broderick, R. Kothari, et Al., Y. Fujii, R. Tanaka, S. Takeuchi, et Al., S. Kazui,
H. Naritomi, H. Yamamoto, et Al., K. Wagner, G. Xi, Y. Hua, et Al., G. Xi,
R. Keep, J. Hoff, K. Lee, A. Betz, S. Kim, et Al., G. Xi, K. Wagner, R. Keep, et Al.,
J. Gebel, C. Sila, M. Sloan, et Al., J. Gebel, T. Brott, C. Sila, et Al., S. Greenberg,
S. Finklestein, P. Schaefer, S. Greenberg, H. O’Donnell, P. Schaefer, et Al., G. Roob,
R. Schmidt, P. Kapeller, et Al., H. Offenbacher, F. Fazekas, R. Schmidt, et Al.,
F. Cole, P. Tates, C. Fisher, R. R. Russell, S. Takebayashi, D. Woo, L. Sauerbeck,
B. Kissela, et Al., H. Okazaki, J. Whisnant, H. Vinters, J. Vonsattel, R. Myers,
E. Hedley-Whyte, et Al., T. Mandybur, S. Bates, K. Maruyama, S. Ikeda, T. Ishi-
hara, et Al., K. Ueda, Y. Hasuo, Y. Kiyohara, et Al., S. Greenberg, J. Vonsattel,
J. Stakes, et Al., M. Tomonaga, H. Vinters, J. Gilbert, I. Drury, J. Whisnant,
W. Garraway, M. Hill, F. Silver, P. Austin, et Al., S. Greenberg, M. Briggs, B. Hy-
man, et Al., S. Greenberg, G. Rebeck, J. Vonsattel, et Al., S. Greenberg, J. Vonsattel,
A. Segal, et Al., J. Nicoll, C. Burnett, S. Love, et Al., H. O’Donnell, J. Rosand,
K. Knudsen, et Al., H. Bevan, K. Sharma, W. Bradley, J. Ruiz-Sandoval, C. Cantu,
F. Barinagarrementeria, G. Toffol, J. Biller, H. Adams, X. Zhu, M. Chan, W. Poon,
M. Sarwar, W. McCormick, Z. Hang, Y. Shi, Y. Wei, R. Brown, D. Wiebers,
J. Torner, et Al., R. Brown, D. Wiebers, G. Forbes, et Al., R. Brown, D. Wiebers,
G. Forbes, P. Crawford, C. West, D. Chadwick, et Al., C. Graf, G. Perret, J. Torner,
Y. Itoyama, S. Uemura, Y. Ushio, et Al., R. Spetzler, R. Hargraves, P. McCormick,
et Al., R. Spetzler, N. Martin, O. D. Curling, D. Kelly, A. Elster, et Al., P. Porter,
R. Willinsky, W. Harper, et Al., D. Rigamonti, M. Hadley, B. Drayer, et Al.,
I. Mason, J. Aase, W. Orrison, et Al., H. Craig, M. Gunel, O. Cepeda, et Al.,
J. Dubovsky, J. Zabramski, J. Kurth, et Al., M. Gunel, I. Awad, J. Anson, et Al.,
M. Gunel, I. Awad, K. Finberg, et Al., M. Gunel, I. Awad, K. Finberg, et Al.,
T. Garner, O. D. Curling, D. Kelly, et Al., D. Kondziolka, P. Dempsey, L. Lunsford,
G. Augustyn, J. Scott, E. Olson, et Al., C. Cammarata, J. Han, J. Haaga, et Al.,
G. Malik, J. Morgan, R. Boulos, et Al., L. Michels, J. Bentson, J. Winter, E. Olson,
R. Gilmor, B. Richmond, Y. Saito, N. Kobayashi, G. Roman, M. Fisher, D. Perl,
et Al., K. Kikuchi, M. Kowada, H. Shioya, et Al., O. Press, P. Ramsey, R. Djindjian,
J. Grollmus, J. Hoff, C. Hodgson, H. Burchell, C. Good, R. Houdart, R. Djindjian,
92
M. Hurth, H. Plauchu, J. de Chadarevian, A. Bideau, et Al., H. Garland, S. An-
ning, C. Smith, L. Bartholomew, J. Cain, A. Bideau, G. Brunet, E. Heyer, et Al.,
A. Bideau, H. Plauchu, A. Jacquard, et Al., K. McAllister, M. Baldwin, A. Thukkani,
et Al., K. McAllister, K. Grogg, D. Johnson, et Al., C. Shovlin, A. Guttmacher,
E. Buscarini, et Al., M. Porteous, J. Burn, S. Proctor, M. Porteous, A. Curtis,
O. Williams, et Al., R. Bird, J. Hammarsten, R. Marshall, et Al., A. Furlan,
J. Whisnant, L. Elveback, A. Wintzen, H. de Jonge, E. Loeliger, et Al., G. Petty,
L. Lennihan, J. Mohr, et Al., T. B. A. A. T. f. A. F. Investigators, G. Albers,
D. Sherman, GD, J. Paulseth, P. Petersen, C. Kase, R. Robinson, R. Stein, et Al.,
J. Radberg, J. Olsson, C. Radberg, N. t.-P. S. S. Group, M. Pfleger, E. Hardee,
C. Contant, et Al., T. Brott, K. Thalinger, V. Hertzberg, H. Okada, H. Horibe,
O. Yoshiyuki, et Al., K. Okumura, K. Iseki, K. Wakugami, et Al., A. Segal, R. Chiu,
P. Eggleston-Sexton, et Al., M. Caicoya, T. Rodriguez, C. Corrales, et Al., R. Mon-
forte, R. Estruch, F. Graus, et Al. and J. Broderick, “Spontaneous intracerebral
hemorrhage: epidemiology and clinical presentation”, Neurosurgery Clinics 13, 3,
265–279 (1990).
Xu, C. and J. Prince, “Snakes, shapes, and gradient vector flow”, Image Processing,
IEEE Transactions on 7, 3, 359 –369 (1998).
Xu, X., X. Chen, J. Zhang, Y. Zheng, G. Sun, X. Yu and B. Xu, “Comparison of
the tada formula with software slicer: Precise and low-cost method for volume
assessment of intracerebral hematoma”, Stroke 45, 11, 3433–3435 (2014).
Xue, W., C. Zwart and J. R. Mitchell, “Intelligent initialization and interactivity:
Optimizing level sets for t1-weighted white matter segmentation”, in “MICCAI
Interactive Medical Image Computing (IMIC) Workshop”, (2014).
Yushkevich, P. a., J. Piven, H. C. Hazlett, R. G. Smith, S. Ho, J. C. Gee and
G. Gerig, “User-guided 3D active contour segmentation of anatomical structures:
significantly improved efficiency and reliability.”, NeuroImage 31, 3, 1116–28, URL
http://www.ncbi.nlm.nih.gov/pubmed/16545965 (2006).
93
